https://curecurrent.com/trials/assessment-of-the-safety-of-adalimumab-in-rheumatoid-arthritis-patients-showing-rapid-progression-of-structural-damage-o-103006https://curecurrent.com/trials/study-to-examine-efficacy-and-safety-of-rituximab-in-participants-with-rheumatoid-arthritis-103007https://curecurrent.com/trials/a-study-to-evaluate-the-safety-and-efficacy-of-mabthera-rituximab-in-combination-with-methotrexate-mtx-in-participants-w-103008https://curecurrent.com/trials/an-observational-study-of-mabthera-in-participants-with-severe-active-rheumatoid-arthritis-103009https://curecurrent.com/trials/use-of-tocilizumab-for-rheumatoid-arthritis-ra-in-daily-routine-103010https://curecurrent.com/trials/a-non-interventional-study-of-roactemra-actemra-tocilizumab-in-patients-with-moderate-to-severe-rheumatoid-arthritis-103011https://curecurrent.com/trials/be-study-in-patients-methotrexate-tablets-103012https://curecurrent.com/trials/premature-coronary-artery-disease-cad-in-severe-psoriasis-103013https://curecurrent.com/trials/safety-and-efficacy-of-extracorporeal-photoimmune-therapy-with-uvadex-for-the-treatment-of-rheumatoid-arthritis-103014https://curecurrent.com/trials/study-for-validation-of-standardized-questionnaires-on-depression-and-investigation-of-the-frequency-of-depression-in-rh-103015https://curecurrent.com/trials/a-study-of-roactemra-actemra-tocilizumab-in-combination-with-methotrexate-in-patients-with-severe-active-rheumatoid-arth-103016https://curecurrent.com/trials/a-non-comparative-study-to-assess-the-safety-of-mabthera-rituximab-in-patients-with-rheumatoid-arthritis-103017https://curecurrent.com/trials/vitamin-d-and-cardiovascular-events-in-rheumatoid-arthritis-103018https://curecurrent.com/trials/ultrasound-evaluation-of-remission-in-rheumatoid-arthritis-103019https://curecurrent.com/trials/a-long-term-extension-study-of-wa22762-and-na25220-of-subcutaneous-sc-tocilizumab-tcz-in-moderate-to-severe-rheumatoid-a-103020https://curecurrent.com/trials/depression-and-anxiety-in-rheumatoid-arthritis-103021https://curecurrent.com/trials/supplementation-with-vitamin-d-calcium-or-both-on-calcium-absorption-and-bone-mineral-content-in-children-with-jra-103022https://curecurrent.com/trials/a-two-centre-study-to-assess-the-long-term-performance-of-the-pinnacle-cup-with-a-metal-on-metal-bearing-in-primary-tota-103023https://curecurrent.com/trials/a-single-centre-study-to-assess-the-long-term-performance-of-the-pinnacle-cup-with-a-ceramic-on-ceramic-bearing-in-prima-103024https://curecurrent.com/trials/safety-of-furestem-ra-inj-in-patients-with-moderate-to-severe-rheumatoid-arthritis-ra-103025https://curecurrent.com/trials/a-non-interventional-study-in-rheumatoid-arthritis-patients-treated-with-tocilizumab-roactemra-actemra-103026https://curecurrent.com/trials/work-interventions-to-improve-employment-outcomes-for-persons-with-rheumatoid-arthritis-and-osteoarthritis-103027https://curecurrent.com/trials/first-in-man-trial-of-nnc0142-0002-in-patients-with-rheumatoid-arthritis-103028https://curecurrent.com/trials/efficacy-of-nnc0142-0002-in-subjects-with-rheumatoid-arthritis-ra-103029https://curecurrent.com/trials/rahelp-org-an-online-self-management-program-for-adults-with-rheumatoid-arthritis-103030https://curecurrent.com/trials/study-to-assess-the-safety-tolerability-and-pharmacokinetics-of-amp-110-in-subjects-with-rheumatoid-arthritis-103031https://curecurrent.com/trials/a-study-of-mavrilimumab-in-subjects-with-moderate-to-severe-rheumatoid-arthritis-103032https://curecurrent.com/trials/observational-study-of-the-genetic-architecture-of-neutrophil-mediated-inflammatory-skin-diseases-103033https://curecurrent.com/trials/efficacy-and-safety-of-mycophenolate-mofetil-in-subjectswithsjogren-s-syndrome-103034https://curecurrent.com/trials/evaluation-of-efficacy-and-safety-of-norspan-in-moderate-to-severe-pain-due-to-osteoarthritis-rheumatoid-arthritis-joint-103035https://curecurrent.com/trials/an-open-label-study-of-roactemra-actemra-tocilizumab-in-patients-with-moderate-to-severe-active-rheumatoid-arthritis-103036https://curecurrent.com/trials/open-label-extension-safety-study-of-procrit-in-patients-with-anemia-of-chronic-disease-due-to-rheumatoid-arthritis-103037https://curecurrent.com/trials/long-term-effects-of-an-early-response-to-certolizumab-pegol-czp-cimzia-in-rheumatoid-arthritis-ra-patients-103038https://curecurrent.com/trials/a-study-to-assess-the-effect-of-bms-986142-on-pharmacokinetics-pk-of-probe-substrates-103039https://curecurrent.com/trials/predictors-of-adherence-to-orencia-103040https://curecurrent.com/trials/efficacy-and-safety-study-of-r935788-tablets-to-treat-rheumatoid-arthritis-103041https://curecurrent.com/trials/phase-i-ii-multiple-dose-lea29y-vs-ctlag4ig-vs-placebo-in-rheumatoid-arthritis-103042https://curecurrent.com/trials/an-observational-study-of-roactemra-actemra-tocilizumab-in-patients-with-rheumatoid-arthritis-103043https://curecurrent.com/trials/validation-of-self-administered-questionnaire-for-assessing-calcium-intake-in-patients-with-multiple-sclerosis-or-chroni-103044https://curecurrent.com/trials/a-phase-3-study-of-abatacept-in-chinese-patients-with-active-rheumatoid-arthritis-and-inadequate-response-to-methotrexat-103045https://curecurrent.com/trials/study-of-the-influence-of-the-expression-of-the-calcium-sensitive-receptor-casr-by-monocytes-in-the-synovial-liquid-on-s-103046https://curecurrent.com/trials/effect-of-a-high-fat-meal-on-the-pharmacokinetics-of-shr0302-and-mass-balance-study-in-healthy-subjects-103047https://curecurrent.com/trials/low-dose-dexamethasone-in-supraclavicular-blocks-103048https://curecurrent.com/trials/effectiveness-and-safety-of-physical-exercises-in-the-improvement-of-the-sleep-quality-regarding-rheumatoid-arthritis-103049https://curecurrent.com/trials/c-o-r-p-u-s-observational-cohort-of-adult-and-child-inflammatory-arthritis-in-france-103050https://curecurrent.com/trials/oral-health-assessment-in-rheumatoid-arthritis-and-other-autoimmune-diseases-anti-tnf-substudy-103051https://curecurrent.com/trials/estimation-of-pentraxin3-and-pgingivalis-levels-in-patients-with-knee-joint-and-gum-diseases-103052https://curecurrent.com/trials/hepatocellular-carcinoma-and-rheumatoid-arthritis-103053https://curecurrent.com/trials/effects-of-lacosamide-on-post-operative-opioid-requirements-after-a-total-hip-arthroplasty-103054https://curecurrent.com/trials/predictability-studies-on-the-efficacy-of-tnf-inhibitors-in-chinese-ra-from-real-world-103055https://curecurrent.com/trials/relationship-between-the-activity-of-rheumatoid-arthritis-and-lymph-node-morphology-and-lymphatics-drainage-103056https://curecurrent.com/trials/effects-of-sustained-reading-on-the-ocular-surface-103057https://curecurrent.com/trials/an-observational-study-of-mabthera-rituximab-in-patients-with-rheumatoid-arthritis-and-inadequate-response-or-intoleranc-103058https://curecurrent.com/trials/repository-corticotropin-injection-to-treat-rheumatoid-arthritis-patients-who-have-failed-three-biologic-therapies-103059https://curecurrent.com/trials/an-observational-study-of-mabthera-rituxan-rituximab-in-patients-with-rheumatoid-arthritis-and-an-inadequate-response-or-103060https://curecurrent.com/trials/progressive-resistance-exercise-in-rheumatoid-arthritis-103061https://curecurrent.com/trials/an-observational-study-of-mabthera-rituxan-rituximab-in-patients-with-sero-positive-rheumatoid-arthritis-who-are-non-res-103062https://curecurrent.com/trials/participation-restrictions-in-rheumatoid-arthritis-103063https://curecurrent.com/trials/evaluating-the-effect-of-anakinra-r-methuil-1ra-on-vaccine-antibodyresponse-in-subjects-with-rheumatoid-arthritis-ra-103064https://curecurrent.com/trials/more-added-value-of-therapeutic-education-in-the-management-of-patients-with-rheumatoid-arthritis-etp-pr-103065https://curecurrent.com/trials/efficacy-of-lodotra-prednisone-in-reduction-of-morning-stiffness-duration-k-improve-103066https://curecurrent.com/trials/modulation-of-immunity-related-gene-expression-under-the-chinese-herbal-formula-ss-1-treatment-for-sj-gren-s-syndrome-103067https://curecurrent.com/trials/multi-centre-study-to-assess-the-long-term-performance-of-the-depuy-asr-system-in-resurfacing-and-primary-total-hip-repl-103068https://curecurrent.com/trials/a-multi-centre-study-to-assess-the-long-term-performance-of-the-summit-hip-in-primary-total-hip-replacement-103069https://curecurrent.com/trials/ultrasound-as-imaging-biomarker-of-early-response-to-tocilizumab-and-methotrexate-in-very-early-rheumatoid-arthritis-103070https://curecurrent.com/trials/a-study-of-mabthera-rituximab-in-patients-with-rheumatoid-arthritis-who-have-had-an-inadequate-response-to-a-single-anti-103071https://curecurrent.com/trials/study-of-the-efficacy-and-safety-of-cholecalciferol-supplementation-on-the-activity-of-rheumatoid-arthritis-in-patients-103072https://curecurrent.com/trials/optical-coherence-tomography-of-ocular-structures-in-epiphora-and-dry-eye-syndrome-103073https://curecurrent.com/trials/the-influence-of-rapid-recovery-on-sleep-quality-following-total-knee-replacement-surgery-103074https://curecurrent.com/trials/minimally-invasive-versus-conventional-approaches-in-navigated-total-knee-arthroplasty-tka-103075https://curecurrent.com/trials/a-study-of-ak106-001616-in-patients-with-rheumatoid-arthritis-ra-103076https://curecurrent.com/trials/a-study-of-ak106-001616-in-patients-with-rheumatoid-arthritis-ra-103077https://curecurrent.com/trials/observational-study-of-tocilizumab-in-participants-with-rheumatoid-arthritis-in-australia-103078https://curecurrent.com/trials/safety-tolerability-pk-pd-and-immunogenicity-of-single-and-multiple-ascending-intravenous-doses-of-fr104-103079https://curecurrent.com/trials/secukinumab-efficacy-and-safety-study-in-patients-with-rheumatoid-arthritis-and-inadequate-response-to-anti-tnf-agents-103080https://curecurrent.com/trials/efficacy-and-safety-of-buprenorphine-transdermal-patch-in-non-cancer-pain-of-moderate-intensity-103081https://curecurrent.com/trials/a-study-of-the-pharmacokinetics-and-safety-of-mk-8808-mk-8808-002-103082https://curecurrent.com/trials/natalizumab-in-the-treatment-of-rheumatoid-arthritis-in-subjects-receiving-methotrexate-103083https://curecurrent.com/trials/a-study-of-tocilizumab-and-methotrexate-in-combination-or-as-monotherapy-in-treatment-na-ve-patients-with-early-rheumato-103084https://curecurrent.com/trials/study-conducted-in-subjects-with-rheumatoid-arthritis-who-have-moderate-to-severe-disease-activity-despite-methotrexate-103085https://curecurrent.com/trials/efficacy-and-safety-study-of-roactemra-tocilizumab-in-participants-with-rheumatoid-arthritis-103086https://curecurrent.com/trials/allied-health-in-rheumatology-triage-project-103087https://curecurrent.com/trials/efficacy-study-of-fang-30-for-active-rheumatoid-arthritis-in-adult-patients-103088https://curecurrent.com/trials/an-observational-study-of-the-impact-of-roactemra-actemra-on-fatigue-in-patients-with-rheumatoid-arthritis-peps-103089https://curecurrent.com/trials/gum-arabic-as-immunomodulator-in-rheumatoid-arthritis-patients-103090https://curecurrent.com/trials/carnet-self-monitoring-and-co-driving-in-rheumatology-with-internet-rheumatoid-arthritis-cohort-usual-care-study-103091https://curecurrent.com/trials/efficacy-and-safety-of-traditional-chinese-medicine-tcm-comprehensive-therapy-in-patients-with-rheumatoid-arthritis-103092https://curecurrent.com/trials/a-study-to-compare-subcutaneous-versus-intravenous-administration-of-roactemra-actemra-tocilizumab-in-participants-with-103093https://curecurrent.com/trials/a-phase-ii-multicenter-open-label-long-term-study-of-the-safety-tolerability-and-efficacy-of-intravenous-natalizumab-in-103094https://curecurrent.com/trials/metal-ions-in-ceramic-on-metal-total-hip-arthroplasty-103095https://curecurrent.com/trials/therapeutic-strategy-in-patients-treated-with-methotrexate-for-rheumatoid-arthritis-103096https://curecurrent.com/trials/99mtc-anti-tnf-alpha-scintigraphy-in-the-evaluation-of-inflammatory-processes-activity-103097https://curecurrent.com/trials/a-study-in-rheumatoid-arthritis-103098https://curecurrent.com/trials/a-study-of-ly2439821-in-rheumatoid-arthritis-103099https://curecurrent.com/trials/a-study-in-patients-with-rheumatoid-arthritis-103100https://curecurrent.com/trials/human-umbilical-cord-mesenchymal-stem-cells-for-rheumatoid-arthritis-103101https://curecurrent.com/trials/efficacy-at-24-weeks-and-safety-tolerability-and-long-term-efficacy-of-secukinumab-ain457-in-patients-with-active-rheuma-103102https://curecurrent.com/trials/retro-reduction-of-therapy-in-ra-patients-in-ongoing-remission-103103https://curecurrent.com/trials/acute-effect-of-resistance-training-in-inflammatory-markers-in-women-with-rheumatoid-arthritis-103104https://curecurrent.com/trials/korean-post-marketing-surveillance-for-orencia-103105https://curecurrent.com/trials/trial-of-a-physical-activity-intervention-for-ra-fatigue-103106https://curecurrent.com/trials/a-study-of-the-effectiveness-and-safety-of-ustekinumab-stelara-and-cnto-1959-administered-under-the-skin-of-patients-wit-103107https://curecurrent.com/trials/effect-on-orencia-abatacept-on-the-apoptosis-of-t-cells-b-cells-and-apc-cells-in-rheumatoid-arthritis-103108https://curecurrent.com/trials/marine-oils-and-arthritis-103109https://curecurrent.com/trials/a-study-of-mabthera-rituximab-in-patients-with-rheumatoid-arthritis-who-have-had-an-inadequate-response-to-a-tnf-blocker-103110https://curecurrent.com/trials/study-to-evaluate-the-safety-tolerability-and-action-of-amg-357-in-females-with-rheumatoid-arthritis-103111https://curecurrent.com/trials/a-study-of-the-safety-tolerability-and-pharmacokinetics-of-hmpl-523-103112https://curecurrent.com/trials/preconceptional-counselling-in-active-rheumatoid-arthritis-103113https://curecurrent.com/trials/iyengar-yoga-for-young-people-with-rheumatoid-arthritis-103114https://curecurrent.com/trials/long-term-clinical-effectiveness-of-the-delta-xtend-reverse-total-shoulder-103115https://curecurrent.com/trials/identification-of-epigenetic-biomarkers-for-early-detection-of-rheumatic-disease-103116https://curecurrent.com/trials/multiple-doses-escalation-study-of-shr0302-in-rheumatoid-arthritis-ra-patients-103117https://curecurrent.com/trials/velvet-a-dose-range-finding-trial-of-veltuzumab-in-subjects-with-moderate-to-severe-rheumatoid-arthritis-103118https://curecurrent.com/trials/a-randomised-trial-comparing-anterior-versus-posterior-approach-in-total-hip-replacement-103119https://curecurrent.com/trials/study-evaluating-long-term-safety-of-atn-103-in-subjects-with-rheumatoid-arthritis-103120https://curecurrent.com/trials/a-phase-3-study-of-ni-071-in-patients-with-rheumatoid-arthritis-103121https://curecurrent.com/trials/rituximab-rtx-for-disease-modifying-anti-rheumatic-drug-dmard-non-responders-in-pakistan-the-pakistan-rituximab-study-pa-103122https://curecurrent.com/trials/sarilumab-effect-on-the-pharmacokinetics-of-simvastatin-103123https://curecurrent.com/trials/activity-limitations-in-rheumatoid-arthritis-103124https://curecurrent.com/trials/an-observational-study-in-clinical-practice-management-of-patients-with-biological-drugs-in-monotherapy-103125https://curecurrent.com/trials/a-study-of-ocrelizumab-in-participants-with-moderate-to-severe-rheumatoid-arthritis-ra-103126https://curecurrent.com/trials/single-dose-study-to-describe-the-safety-of-sarilumab-and-tocilizumab-in-patients-with-rheumatoid-arthritis-103127https://curecurrent.com/trials/a-non-interventional-study-of-roactemra-actemra-in-patients-with-moderate-to-severe-rheumatoid-arthritis-103128https://curecurrent.com/trials/addition-of-rituximab-to-leflunomide-in-patients-with-active-rheumatoid-arthritis-103129https://curecurrent.com/trials/differences-in-bone-cell-activity-between-rheumatoid-arthritis-and-ankylosing-spondylitis-103130https://curecurrent.com/trials/effects-of-underwater-ultrasound-therapy-on-hand-function-and-quality-of-life-in-patients-with-rheumatoid-arthritis-103131https://curecurrent.com/trials/special-investigation-in-patients-with-rheumatoid-arthritis-hopeful-iii-study-a-follow-up-survey-of-study-p12-069-103132https://curecurrent.com/trials/study-to-assess-the-management-of-synthetic-disease-modifying-antirheumatic-drug-dmard-at-the-onset-of-adverse-events-in-103133https://curecurrent.com/trials/observational-study-of-roactemra-actemra-tocilizumab-in-patients-with-rheumatoid-arthritis-103134https://curecurrent.com/trials/a-study-to-assess-the-safety-tolerability-and-pharmacokinetics-of-multiple-subcutaneous-injections-of-abbv-257-in-subjec-103135https://curecurrent.com/trials/reciprocating-medical-devices-a-study-of-a-new-safety-device-103136https://curecurrent.com/trials/an-efficacy-and-safety-study-of-cnto-6785-in-participants-with-active-rheumatoid-arthritis-despite-methotrexate-therapy-103137https://curecurrent.com/trials/acupuncture-for-primary-sj-gren-syndrome-103138https://curecurrent.com/trials/endothelial-dysfunction-evaluation-for-coronary-heart-disease-risk-estimation-in-rheumatoid-arthritis-edra-study-103139https://curecurrent.com/trials/the-effect-of-neurodynamic-mobilization-exercise-on-lower-limb-pain-in-patients-with-rheumatoid-arthritis-103140https://curecurrent.com/trials/immunogenicity-and-safety-of-vaccinations-in-immunocompromised-persons-103141https://curecurrent.com/trials/real-life-evaluation-of-rheumatoid-arthritis-in-canadians-taking-humira-103142https://curecurrent.com/trials/long-term-efficacy-of-iguratimod-alone-or-iguratimod-in-combination-with-methotrexate-in-patients-with-rheumatoid-arthri-103143https://curecurrent.com/trials/nfkb1-and-ikk-epsilon-in-rheumatoid-arthritis-103144https://curecurrent.com/trials/an-observational-study-on-the-safety-and-effectiveness-of-rituximab-in-patients-with-severe-active-rheumatoid-arthritis-103145https://curecurrent.com/trials/real-life-evaluation-of-rheumatoid-arthritis-patients-in-israel-treated-with-humira-103146https://curecurrent.com/trials/a-phase-2-dose-finding-study-of-atacicept-in-subjects-with-rheumatoid-arthritis-august-i-103147https://curecurrent.com/trials/atacicept-in-anti-tumor-necrosis-factor-alpha-na-ve-subjects-with-rheumatoid-arthritis-august-ii-103148https://curecurrent.com/trials/bow015-infliximab-epirus-and-infliximab-in-patients-with-active-rheumatoid-arthritis-the-uniform-study-103149https://curecurrent.com/trials/an-global-comparative-observational-study-of-roactemra-actemra-tocilizumab-in-patients-with-rheumatoid-arthritis-103150https://curecurrent.com/trials/patient-reported-efficacy-of-subcutaneous-sc-abatacept-in-rheumatoid-arthritis-ra-south-africa-103151https://curecurrent.com/trials/a-study-to-assess-efficacy-with-respect-to-clinical-improvement-in-disease-activity-and-safety-of-tocilizumab-in-patient-103152https://curecurrent.com/trials/concomitant-use-of-apremilast-for-the-treatment-of-active-ra-despite-tnf-inhibition-and-methotrexate-catara-103153https://curecurrent.com/trials/factors-associated-with-biologic-dmard-switching-103154https://curecurrent.com/trials/prevalence-of-dry-eye-disease-in-patients-diagnosed-with-rheumatoid-arthritis-103155https://curecurrent.com/trials/an-observational-quality-of-life-study-in-participants-with-rheumatoid-arthritis-treated-with-rituximab-103156https://curecurrent.com/trials/evaluation-of-the-efficacy-and-the-mechanism-of-chinese-herbal-formula-ss-1-for-sj-gren-s-syndrome-103157https://curecurrent.com/trials/study-to-investigate-the-effect-of-bms-986142-on-the-pharmacokinetics-pk-of-methotrexate-and-probe-substrate-cocktail-in-103158https://curecurrent.com/trials/first-in-human-single-ascending-dose-of-shr0302-103159https://curecurrent.com/trials/rheumatic-diseases-and-computer-use-103160https://curecurrent.com/trials/bg9924-in-combination-with-methotrexate-extension-of-study-104ra203-nct-00458861-103161https://curecurrent.com/trials/assessment-of-the-safety-and-efficacy-of-bg9924-in-rheumatoid-arthritis-ra-participants-103162https://curecurrent.com/trials/104ra204-assessment-of-the-safety-and-efficacy-of-bg9924-in-rheumatoid-arthritis-ra-participants-103163https://curecurrent.com/trials/bg9924-in-combination-with-methotrexate-for-participants-with-active-rheumatoid-arthritis-103164https://curecurrent.com/trials/correlation-between-beliefs-about-medicine-and-objective-measures-of-efficacy-and-safety-in-rheumatoid-arthritis-ra-103165https://curecurrent.com/trials/an-animated-home-based-physical-exercise-program-as-a-treatment-option-for-patients-with-rheumatoid-arthritis-103166https://curecurrent.com/trials/open-label-study-comparing-etanercept-to-conventional-disease-modifying-antirheumatic-drug-dmard-therapy-103167https://curecurrent.com/trials/efficacy-and-safety-study-of-abatacept-subcutaneous-plus-methotrexate-in-inducing-remission-in-adults-with-very-early-rh-103168https://curecurrent.com/trials/hair-fall-in-patients-on-low-dose-methotrexate-103169https://curecurrent.com/trials/inhibition-of-co-stimulation-in-rheumatoid-arthritis-103170https://curecurrent.com/trials/drug-concentration-immunogenicity-and-efficacy-study-in-patients-with-rheumatoid-arthritis-currently-treated-with-etaner-103171https://curecurrent.com/trials/a-study-comparing-lbec0101-to-enbrel-in-subjects-with-active-rheumatoid-arthritis-despite-methotrexate-therapy-103172https://curecurrent.com/trials/registry-for-african-americans-with-early-rheumatoid-arthritis-103173https://curecurrent.com/trials/study-of-etanercept-in-subjects-with-rheumatoid-arthritis-who-have-had-an-inadequate-response-to-adalimumab-or-inflixima-103174https://curecurrent.com/trials/safety-and-pharmacokinetics-study-of-xoma-052-in-subjects-with-active-stable-moderate-to-severe-rheumatoid-arthritis-103175https://curecurrent.com/trials/study-to-evaluate-the-efficacy-of-tacrolimus-in-rheumatoid-arthritis-patients-shown-unsuccessful-response-to-methotrexat-103176https://curecurrent.com/trials/help-arthritis-with-exercise-in-west-virginia-103177https://curecurrent.com/trials/comparative-study-of-thymosin-beta-4-eye-drops-vs-vehicle-in-the-treatment-of-severe-dry-eye-103178https://curecurrent.com/trials/pilot-study-of-raptiva-to-treat-sjogren-s-syndrome-103179https://curecurrent.com/trials/evaluation-of-the-reproducibility-inter-observer-of-the-ultrasound-anomalies-of-the-salivary-glands-in-sjogren-s-disease-103180https://curecurrent.com/trials/periodontal-disease-and-circulatory-microbial-components-103181https://curecurrent.com/trials/risk-of-coccidioidomycosis-in-patients-receiving-anti-tnf-and-other-biologic-agents-for-an-inflammatory-arthritis-103182https://curecurrent.com/trials/safety-and-effectiveness-of-rilonacept-for-treating-systemic-juvenile-idiopathic-arthritis-in-children-and-young-adults-103183https://curecurrent.com/trials/study-evaluating-cci-779-in-active-rheumatoid-arthritis-on-concomitant-methotrexate-therapy-103184https://curecurrent.com/trials/prediction-of-erosive-disease-in-early-rheumatoid-arthritis-ra-by-ultrasound-and-cartilage-biodegradation-markers-103185https://curecurrent.com/trials/a-study-of-roactemra-actemra-tocilizumab-plus-dmards-in-patients-with-rheumatoid-arthritis-103186https://curecurrent.com/trials/a-study-to-assess-the-safety-and-effectiveness-of-golimumab-in-filipino-patients-with-rheumatoid-arthritis-psoriatic-art-103187https://curecurrent.com/trials/post-marketing-surveillance-study-of-remicade-in-patients-with-chronic-inflammatory-diseases-p04840-103188https://curecurrent.com/trials/study-to-characterize-the-pharmacokinetics-of-a-single-dose-of-sc-abatacept-125-mg-using-the-bd-autoinjector-or-the-pref-103189https://curecurrent.com/trials/long-term-efficacy-and-safety-of-ct-p10-in-patients-with-ra-103190https://curecurrent.com/trials/activity-rheumatoid-and-osteoarthritis-and-weight-management-103191https://curecurrent.com/trials/optimized-treatment-algorithm-for-patients-with-early-rheumatoid-arthritis-ra-103192https://curecurrent.com/trials/an-observational-study-of-roactemra-actemra-tocilizumab-in-monotherapy-in-patients-with-rheumatoid-arthritis-103193https://curecurrent.com/trials/24-week-study-with-open-label-extension-of-vx-509-an-oral-jak3-inhibitor-in-subjects-taking-methotrexate-103194https://curecurrent.com/trials/efficacy-and-safety-study-of-mk0359-in-patients-with-arthritis-0359-017-103195https://curecurrent.com/trials/a-phase-2-3-open-label-extension-study-to-evaluate-long-term-safety-and-efficacy-with-vx-509-in-subjects-with-rheumatoid-103196https://curecurrent.com/trials/hepatitis-a-vaccine-in-patients-with-immunomodulating-drugs-103197https://curecurrent.com/trials/three-doses-of-hepatitis-a-vaccine-in-patients-with-immunomodulating-drugs-103198https://curecurrent.com/trials/tear-proteins-conjunctival-cells-and-imaging-eyes-in-rheumatoid-arthritis-and-systemic-lupus-erythematosus-patients-103199https://curecurrent.com/trials/long-term-treatment-study-of-cdp870-self-injection-in-patients-with-active-rheumatoid-arthritis-who-are-participating-in-103200https://curecurrent.com/trials/safety-and-tolerability-of-morab-022-in-healthy-and-rheumatoid-arthritis-subjects-103201https://curecurrent.com/trials/certolizumab-pegol-for-the-treatment-of-patients-with-active-rheumatoid-arthritis-ra-and-crohn-s-disease-cd-103202https://curecurrent.com/trials/greek-study-on-work-productivity-and-sleep-in-patients-with-rheumatic-diseases-treated-with-adalimumab-103203https://curecurrent.com/trials/methotrexate-inadequate-response-study-103204https://curecurrent.com/trials/safety-and-efficacy-of-the-combination-of-diacerein-100-mg-daily-and-mtx-versus-mtx-alone-in-the-treatment-of-early-rheu-103205https://curecurrent.com/trials/a-safety-and-efficacy-study-of-golimumab-cnto148-in-patients-with-active-rheumatoid-arthritis-ra-103206https://curecurrent.com/trials/a-study-of-roactemra-actemra-tocilizumab-in-patients-with-moderate-to-severe-rheumatoid-arthritis-103207https://curecurrent.com/trials/consequences-of-anti-interleukin-6-immunotherapy-treatment-for-rheumatoid-arthritis-on-periodontium-103208https://curecurrent.com/trials/study-to-assess-safety-tolerability-and-pharmacokinetics-of-oral-doses-for-ac430-in-healthy-subjects-103209https://curecurrent.com/trials/efficacy-safety-and-tolerability-of-ain457-in-patients-with-rheumatoid-arthritis-ra-taking-methotrexate-mtx-103210https://curecurrent.com/trials/observation-of-treatment-with-certolizumab-pegol-in-daily-practice-103211https://curecurrent.com/trials/mexican-initiative-of-patients-with-osteoarthritis-and-rheumatoid-arthritis-impactar-103212https://curecurrent.com/trials/efficacy-tolerability-and-safety-study-in-rheumatoid-arthritis-0812-008-103213https://curecurrent.com/trials/associations-between-periodontitis-and-autoimmune-antibodies-in-rheumatoid-arthritis-disease-103214https://curecurrent.com/trials/evaluation-of-ocular-surface-inflammatory-mediators-effected-by-lotemax-103215https://curecurrent.com/trials/treatment-efficacy-and-toxicity-in-rheumatoid-arthritis-database-and-repository-103216https://curecurrent.com/trials/poc-in-rheumatoid-arthritis-with-methotrexate-103217https://curecurrent.com/trials/proof-of-concept-study-with-bms-817399-to-treat-moderate-to-severe-rheumatoid-arthritis-103218https://curecurrent.com/trials/the-efficacy-and-safety-of-fang-yi-qing-feng-shi-granules-in-subjects-with-rheumatoid-arthritis-103219https://curecurrent.com/trials/intervention-with-long-chain-n-3-polyunsaturated-fatty-acids-from-microalgae-oil-in-patients-with-rheumatoid-arthritis-103220https://curecurrent.com/trials/a-dose-block-randomized-placebo-controlled-double-blind-active-controlled-open-label-dose-escalation-study-103221https://curecurrent.com/trials/a-retrospective-observational-chart-review-of-biologics-in-monotherapy-versus-the-combination-biologic-plus-methotrexate-103222https://curecurrent.com/trials/special-drug-use-results-survey-of-prograf-capsule-in-rheumatoid-arthritis-patients-103223https://curecurrent.com/trials/determining-how-the-nervous-system-processes-pain-in-adults-with-fibromyalgia-103224https://curecurrent.com/trials/a-study-of-ly3090106-in-healthy-participants-and-participants-with-rheumatoid-arthritis-ra-103225https://curecurrent.com/trials/efficacy-and-safety-of-etanercept-in-active-ra-despite-methotrexate-therapy-in-japan-103226https://curecurrent.com/trials/evaluation-of-the-effect-of-acupuncture-on-hand-pain-functional-deficits-and-health-related-quality-of-life-in-patients-103227https://curecurrent.com/trials/safety-and-tolerability-of-rituxan-with-methotrexate-and-etanercept-or-methotrexate-and-adalimumab-in-patients-with-acti-103228https://curecurrent.com/trials/a-study-to-validate-questionnaires-flare-and-om-ra-flare-measuring-disease-flares-in-patients-with-rheumatoid-arthritis-103229https://curecurrent.com/trials/certolizumab-and-lower-extremity-lymph-flow-in-rheumatoid-arthritis-ra-103230https://curecurrent.com/trials/incidence-and-risk-factor-of-hydroxychloroquine-and-chloroquine-retinopathy-103231https://curecurrent.com/trials/a-randomized-placebo-controlled-double-blind-single-ascending-dose-study-to-evaluate-the-safety-tolerability-pharmacokin-103232https://curecurrent.com/trials/sudoscan-in-patients-with-autoimmune-disorders-103233https://curecurrent.com/trials/does-etanercept-influence-tweak-modulation-of-inflammation-during-inflammatory-rheumatisms-psoriatic-arthritis-and-rheum-103234https://curecurrent.com/trials/genetic-registry-for-rheumatoid-arthritis-103235https://curecurrent.com/trials/a-study-of-roactemra-actemra-and-if-initially-inadequately-responded-to-roactemra-actemra-followed-by-mabthera-rituxan-i-103236https://curecurrent.com/trials/safety-and-effectiveness-of-infliximab-in-slovakia-when-used-for-rheumatoid-arthritis-study-p04741-completed-103237https://curecurrent.com/trials/effects-of-fasting-on-self-efficacy-103238https://curecurrent.com/trials/remicade-safety-line-study-p03236-completed-103239https://curecurrent.com/trials/real-life-dosing-of-remicade-for-rheumatoid-arthritis-in-austria-monitored-over-9-infusions-study-p03756-completed-103240https://curecurrent.com/trials/pharmacokinetic-study-to-compare-the-blood-levels-of-low-vs-high-metal-manufacture-of-abatacept-103241https://curecurrent.com/trials/treatment-of-hypovitaminosis-d-in-rheumatoid-arthritis-103242https://curecurrent.com/trials/a-study-of-rabeprazole-for-prevention-of-non-steroidal-anti-inflammatory-drug-associated-gastroduodenal-injury-103243https://curecurrent.com/trials/a-trial-to-evaluate-the-safety-and-tolerability-of-namilumab-mt203-in-patients-with-mild-to-moderate-rheumatoid-arthriti-103244https://curecurrent.com/trials/clinical-disease-activity-and-modulation-of-synovial-lymphoid-structures-and-b-cell-function-in-rheumatoid-arthritis-103245https://curecurrent.com/trials/wireless-motion-sensors-for-rheumatoid-arthritis-patients-pilot-study-103246https://curecurrent.com/trials/adalimumab-in-rheumatoid-arthritis-an-investigation-of-wholebody-mri-conventional-mri-ct-and-circulating-biomarkers-103247https://curecurrent.com/trials/evaluation-by-hr-pqct-of-bone-microarchitecture-changes-in-patients-with-rheumatoid-arthritis-under-anti-tnf-therapy-103248https://curecurrent.com/trials/a-study-in-patients-with-moderate-to-severe-active-rheumatoid-arthritis-comparing-different-infusion-durations-of-roacte-103249https://curecurrent.com/trials/efficacy-and-safety-study-of-tacrobell-to-treat-rheumatoid-arthritis-103250https://curecurrent.com/trials/a-biomarker-study-of-secukinumab-in-rheumatoid-arthritis-ra-patients-103251https://curecurrent.com/trials/study-comparing-etanercept-in-combination-with-methotrexate-in-subjects-with-rheumatoid-arthritis-103252https://curecurrent.com/trials/vitamin-d-deficiency-causes-immune-dysfunction-and-enables-or-perpetuates-the-development-of-rheumatoid-arthritis-103253https://curecurrent.com/trials/a-study-to-observe-characteristics-of-rheumatoid-arthritis-in-patients-using-infliximab-study-p04250-103254https://curecurrent.com/trials/rheumatoid-arthritis-patients-on-adalimumab-to-evaluate-its-effect-on-synovitis-using-ultrasonography-in-an-egyptian-pop-103255https://curecurrent.com/trials/a-study-of-a-novel-investigational-drug-in-rheumatoid-arthritis-patients-mk-0873-012-completed-103256https://curecurrent.com/trials/a-study-of-roactemra-actemra-tocilizumab-given-subcutaneously-in-combination-with-traditional-dmards-in-patients-with-mo-103257https://curecurrent.com/trials/methotrexate-inadequate-response-autoinjector-device-sub-study-103258https://curecurrent.com/trials/impact-of-adalimumab-therapy-on-brachial-endothelial-function-and-large-artery-stiffness-in-patients-with-rheumatoid-art-103259https://curecurrent.com/trials/an-exploratory-study-of-tocilizumab-in-patients-with-active-rheumatoid-arthritis-ra-and-an-inadequate-response-to-curren-103260https://curecurrent.com/trials/a-study-of-roactemra-actemra-tocilizumab-with-or-without-methotrexate-in-patients-with-mild-to-moderate-rheumatoid-arthr-103261https://curecurrent.com/trials/safety-profile-of-nulojix-in-home-infusion-settings-103262https://curecurrent.com/trials/a-study-of-roactemra-actemra-tocilizumab-in-combination-with-methotrexate-versus-roactemra-actemra-monotherapy-in-patien-103263https://curecurrent.com/trials/acetabular-shell-positioning-using-patient-specific-instruments-103264https://curecurrent.com/trials/a-synovial-biopsy-study-of-jnj-38518168-in-participants-with-active-rheumatoid-arthritis-despite-methotrexate-therapy-103265https://curecurrent.com/trials/tight-control-of-disease-activity-among-patients-with-ra-based-on-a-systematic-telemedicine-treatment-strategy-103266https://curecurrent.com/trials/study-evaluating-the-analgesic-efficacy-and-safety-of-adl5859-in-participants-with-rheumatoid-arthritis-103267https://curecurrent.com/trials/safety-tolerability-and-pharmacokinetics-of-gs-5745-in-subjects-with-rheumatoid-arthritis-103268https://curecurrent.com/trials/pilot-study-of-ultrasound-in-rheumatoid-arthritis-103269https://curecurrent.com/trials/cardiovascular-risk-markers-in-patients-with-rheumatoid-arthritis-effect-of-rituximab-therapy-103270https://curecurrent.com/trials/efficacy-and-safety-study-of-mizoribine-in-active-rheumatoid-amoled-103271https://curecurrent.com/trials/evaluation-of-the-role-of-adalimumab-on-extraarticular-manifestation-bone-metabolism-and-bone-mineral-density-in-patient-103272https://curecurrent.com/trials/giop-prevention-among-people-with-rheumatoid-arthritis-103273https://curecurrent.com/trials/ultrasound-scores-as-indication-of-response-to-subcutaneous-abatacept-in-subjects-with-rheumatoid-arthritis-103274https://curecurrent.com/trials/special-investigation-of-humira-adalimumab-on-long-term-treatment-in-patients-with-rheumatoid-arthritis-103275https://curecurrent.com/trials/a-trial-to-determine-the-effects-of-exercise-in-inflammatory-bowel-disease-and-rheumatoid-arthritis-103276https://curecurrent.com/trials/12-week-no-rofecoxib-plus-aspirin-endoscopy-study-0782-003-103277https://curecurrent.com/trials/examination-of-biopsies-from-healthy-knee-joints-103278https://curecurrent.com/trials/assessment-of-the-disease-severity-and-treatment-patterns-of-rheumatoid-arthritis-in-eastern-europe-middle-east-and-nort-103279https://curecurrent.com/trials/a-study-of-immune-cells-in-patients-with-rheumatoid-arthritis-during-different-types-of-anti-tnf-alpha-treatments-study-103280https://curecurrent.com/trials/autoantibodies-to-gastric-parietal-cells-in-rheumatoid-arthritis-patients-103281https://curecurrent.com/trials/a-study-of-the-effects-of-oral-prednisone-in-patients-with-rheumatoid-arthritis-mk0000-088-103282https://curecurrent.com/trials/optimal-management-of-rheumatoid-arthritis-patients-requiring-biologic-therapy-103283https://curecurrent.com/trials/exercise-induced-improvements-of-inflammatory-status-in-patients-with-rheumatoid-arthritis-103284https://curecurrent.com/trials/effects-of-tranilast-on-pharmacokinetics-of-methotrexate-mtx-in-patients-with-rheumatoid-arthritis-ra-103285https://curecurrent.com/trials/uncontrolled-study-to-evaluate-efficacy-of-tocilizumab-in-patients-with-moderate-or-severe-rheumatoid-arthritis-103286https://curecurrent.com/trials/demonstrate-the-equivalence-of-ct-p10-to-mabthera-with-respect-to-the-pharmacokinetic-profile-in-patients-with-rheumatoi-103287https://curecurrent.com/trials/aminopterin-dose-finding-treatment-for-methotrexate-na-ve-rheumatoid-arthritis-103288https://curecurrent.com/trials/a-magnetic-resonance-imaging-study-and-arthroscopic-biopsy-substudy-in-subjects-with-active-rheumatoid-arthritis-receivi-103289https://curecurrent.com/trials/diagnostic-value-of-oral-prednisolone-test-for-rheumatoid-arthritis-103290https://curecurrent.com/trials/safety-pk-pd-food-effect-study-of-orally-administered-hm71224-in-healthy-adult-male-volunteers-103291https://curecurrent.com/trials/metal-on-metal-versus-metal-on-highly-crossed-linked-polyethylene-sytem-103292https://curecurrent.com/trials/a-study-to-assess-the-effect-of-tocilizumab-plus-methotrexate-on-safety-and-signs-and-symptoms-in-patients-with-moderate-103293https://curecurrent.com/trials/a-study-to-investigate-the-effect-of-28-days-of-dosing-with-gw856553-on-patients-with-rheumatoid-arthritis-103294https://curecurrent.com/trials/long-term-open-label-study-of-cp-690-550-for-treatment-of-rheumatoid-arthritis-in-japan-103295https://curecurrent.com/trials/effects-of-rosuvastatin-on-carotid-artery-plaques-in-patients-with-inflammatory-joint-disease-103296https://curecurrent.com/trials/addition-of-h-p-acthar-gel-to-treatment-regimen-of-patients-with-rheumatoid-arthritis-103297https://curecurrent.com/trials/single-dose-study-to-describe-the-pharmacodynamics-pd-and-safety-of-sarilumab-regn88-sar153191-and-tocilizumab-in-adults-103298https://curecurrent.com/trials/a-study-of-retreatment-with-mabthera-rituximab-in-combination-with-methotrexate-in-patients-with-rheumatoid-arthritis-ra-103299https://curecurrent.com/trials/golimumab-in-rheumatoid-arthritis-participants-with-an-inadequate-response-to-etanercept-enbrel-or-adalimumab-humira-103300https://curecurrent.com/trials/centocor-microarray-study-of-patients-103301https://curecurrent.com/trials/phase-iiib-subcutaneous-missed-dose-study-103302https://curecurrent.com/trials/effects-of-tofacitinib-cp-690-550-on-magnetic-resonance-imaging-mri-assessed-joint-structure-in-early-rheumatoid-arthrit-103303https://curecurrent.com/trials/aiming-for-remission-in-rheumatoid-arthritis-ra-the-arctic-trial-103304https://curecurrent.com/trials/a-study-to-test-the-design-functionality-and-ergonomic-features-of-the-autoinjector-103305https://curecurrent.com/trials/a-study-of-rituximab-mabthera-rituxan-in-patients-with-rheumatoid-arthritis-and-inadequate-response-to-methotrexate-103306https://curecurrent.com/trials/pharmaco-kinetic-variability-of-infliximab-in-rheumatoid-arthritis-103307https://curecurrent.com/trials/draining-pln-and-synovial-inflammation-in-ra-knee-joints-pre-and-post-anti-tnf-or-b-cell-depletion-therapy-103308https://curecurrent.com/trials/a-clinical-study-of-a-natural-remedy-for-rheumatoid-arthritis-vs-commonly-used-conventional-medications-103309https://curecurrent.com/trials/study-of-abatacept-versus-placebo-to-assess-the-prevention-of-rheumatoid-arthritis-ra-in-adult-patients-103310https://curecurrent.com/trials/tnf-blocking-therapy-in-combination-with-disease-modifying-antirheumatic-drugs-in-early-rheumatoid-arthritis-103311https://curecurrent.com/trials/efficacy-study-of-dextromethorphan-to-treat-rheumatoid-arthritis-103312https://curecurrent.com/trials/double-blind-placebo-controlled-study-of-the-safety-tolerability-and-pharmacokinetics-of-ain457-in-rheumatoid-arthritis-103313https://curecurrent.com/trials/a-study-of-the-safety-of-rituxan-in-patients-with-rheumatoid-arthritis-after-an-inadequate-response-to-previous-anti-tnf-103314https://curecurrent.com/trials/validation-of-a-tolerability-questionnaire-in-rheumatoid-arthritis-103315https://curecurrent.com/trials/quantification-of-gadd34-expression-in-ra-103316https://curecurrent.com/trials/study-of-gammalinolenic-acid-for-juvenile-rheumatoid-arthritis-103317https://curecurrent.com/trials/a-study-to-evaluate-the-efficacy-safety-and-pharmacokinetics-pharmacodynamics-pk-pd-of-ocrelizumab-in-patients-with-rheu-103318https://curecurrent.com/trials/abatacept-and-infliximab-in-combination-with-methotrexate-in-subjects-with-rheumatoid-arthritis-103319https://curecurrent.com/trials/a-study-exploring-the-safety-tolerability-and-efficacy-of-a-4-week-course-of-incb018424-in-subjects-with-active-rheumato-103320https://curecurrent.com/trials/phase-iiib-subcutaneous-abatacept-monotherapy-study-103321https://curecurrent.com/trials/green-tea-lozenges-for-the-management-of-dry-mouth-103322https://curecurrent.com/trials/safety-pharmacokinetic-pk-pharmcodynamic-pd-and-drug-drug-interaction-of-plx3397-in-patients-with-rheumatoid-arthritis-w-103323https://curecurrent.com/trials/evaluation-of-patient-performance-using-the-metoject-device-for-subcutaneous-injection-in-rheumatoid-arthritis-ra-patien-103324https://curecurrent.com/trials/bovine-intestinal-alkaline-phosphatase-biap-modulating-rheumatoid-arthritis-103325https://curecurrent.com/trials/descriptive-study-in-patients-treated-with-vimovo-including-registration-of-the-physicians-prescribing-patterns-103326https://curecurrent.com/trials/phase-iiib-switching-from-intravenous-to-subcutaneous-study-103327https://curecurrent.com/trials/pilot-study-of-total-body-irradiation-in-combination-with-cyclophosphamide-anti-thymocyte-globulin-and-autologous-cd34-s-103328https://curecurrent.com/trials/evaluation-of-non-surgical-periodontal-therapy-in-patients-with-rheumatoid-arthritis-103329https://curecurrent.com/trials/introducing-a-single-iv-abatacept-treatment-in-ra-patients-currently-receiving-weekly-sc-abatacept-to-simulate-a-holiday-103330https://curecurrent.com/trials/efficacy-safety-and-tolerability-of-secukinumab-in-patients-with-rheumatoid-arthritis-taking-methotrexate-103331https://curecurrent.com/trials/an-open-label-study-with-tocilizumab-in-patients-with-rheumatoid-arthritis-in-a-local-environment-103332https://curecurrent.com/trials/comparative-pharmacokinetic-trial-of-rgb-03-and-mabthera-103333https://curecurrent.com/trials/incb047986-in-rheumatoid-arthritis-103334https://curecurrent.com/trials/dose-finding-of-multiple-dose-of-bt061-in-patients-with-active-rheumatoid-arthritis-incompletely-controlled-on-stable-me-103335https://curecurrent.com/trials/study-looking-at-longitudinal-changes-in-fatigue-and-health-status-in-rheumatoid-arthritis-ra-patients-treated-with-subc-103336https://curecurrent.com/trials/assessing-the-impact-of-movalis-in-osteoarthritis-and-rheumatoid-arthritis-patients-on-health-related-quality-of-life-103337https://curecurrent.com/trials/assessment-of-wrist-joint-and-knee-joint-inflammation-in-patients-with-rheumatoid-arthritis-by-quantitative-three-dimens-103338https://curecurrent.com/trials/the-canadian-follow-up-program-for-the-attract-study-p04868-terminated-103339https://curecurrent.com/trials/rheumatoid-arthritis-through-education-and-us-study-raeus-103340https://curecurrent.com/trials/success-of-tocilizumab-in-ra-patients-with-remission-induction-and-sustained-efficacy-after-discontinuation-103341https://curecurrent.com/trials/a-study-of-glucocorticoid-use-to-evaluate-systematic-methylprednisolone-reduction-in-patients-with-rheumatoid-arthritis-103342https://curecurrent.com/trials/role-of-oral-and-intestinal-microbiota-in-rheumatoid-arthritis-ra-103343https://curecurrent.com/trials/a-double-blind-placebo-controlled-single-dose-study-to-evaluate-the-pk-im-and-safety-in-japanese-subjects-103344https://curecurrent.com/trials/a-study-of-combination-treatment-with-mabthera-rituximab-and-roactemra-tocilizumab-versus-roactemra-in-patients-with-rhe-103345https://curecurrent.com/trials/tiv-and-high-dose-tiv-in-subjects-with-rheumatoid-arthritis-103346https://curecurrent.com/trials/safety-study-of-prtx-100-with-methotrexate-or-leflunomide-to-treat-active-rheumatoid-arthritis-103347https://curecurrent.com/trials/safety-and-tolerability-of-nnc0141-0000-0100-in-subjects-with-rheumatoid-arthritis-103348https://curecurrent.com/trials/a-clinical-study-of-xin-an-medicine-in-the-treatment-of-bi-syndrome-103349https://curecurrent.com/trials/effect-of-debridement-scaling-on-the-relief-of-dry-eye-signs-and-symptoms-in-sjogren-s-syndrome-103350https://curecurrent.com/trials/can-creatine-supplementation-improve-body-composition-and-physical-function-in-rheumatoid-arthritis-patients-103351https://curecurrent.com/trials/effects-of-interleukin-1-inhibition-on-vascular-and-left-ventricular-function-in-rheumatoid-arthritis-patients-with-coro-103352https://curecurrent.com/trials/consortium-for-the-longitudinal-evaluation-of-african-americans-with-early-rheumatoid-arthritis-the-clear-registry-103353https://curecurrent.com/trials/leflunomide-versus-sulfasalazine-methotrexate-in-rheumatoid-arthritis-an-ultrasound-magnetic-resonance-imaging-study-103354https://curecurrent.com/trials/the-predictive-value-of-ultrasound-in-early-rheumatoid-arthritis-103355https://curecurrent.com/trials/efficacy-of-monthly-ibandronate-in-women-with-ra-and-reduced-bone-mineral-density-receiving-long-term-steroids-103356https://curecurrent.com/trials/milnacipran-in-the-treatment-of-widespread-non-joint-pain-in-rheumatoid-arthritis-103357https://curecurrent.com/trials/a-study-of-the-effects-of-roactemra-actemra-tocilizumab-on-neutrophils-in-patients-with-active-rheumatoid-arthritis-who-103358https://curecurrent.com/trials/inflammation-and-insulin-resistance-in-rheumatoid-arthritis-103359https://curecurrent.com/trials/a-study-of-roactemra-actemra-tocilizumab-in-combination-with-dmards-versus-current-best-practice-dmard-therapy-in-patien-103360https://curecurrent.com/trials/a-study-of-roactemra-actemra-tocilizumab-in-combination-with-methotrexate-in-patients-with-active-rheumatoid-arthritis-w-103361https://curecurrent.com/trials/maraviroc-in-rheumatoid-arthritis-103362https://curecurrent.com/trials/a-study-of-mabthera-rituximab-in-combination-with-methotrexate-in-patients-with-rheumatoid-arthritis-who-have-had-an-ina-103363https://curecurrent.com/trials/infliximab-plus-methotrexate-for-the-treatment-of-rheumatoid-arthritis-103364https://curecurrent.com/trials/long-term-treatment-study-of-certolizumab-pegol-without-coadministration-of-methotrexate-in-japanese-rheumatoid-arthriti-103365https://curecurrent.com/trials/long-term-treatment-study-of-certolizumab-pegol-cdp870-as-add-on-medication-to-methotrexate-in-japanese-rheumatoid-arthr-103366https://curecurrent.com/trials/study-in-rheumatoid-arthritis-for-subjects-who-completed-preceding-study-m13-390-with-adalimumab-103367https://curecurrent.com/trials/observational-study-of-meloxicam-in-any-labeled-indication-103368https://curecurrent.com/trials/study-of-iguratimod-plus-methotrexate-compared-to-leflunomid-plus-methotrexate-in-patients-with-rheumatoid-arthritis-103369https://curecurrent.com/trials/safety-and-preliminary-efficacy-of-mor103-in-patients-with-active-rheumatoid-arthritis-103370https://curecurrent.com/trials/effectiveness-of-iguratimod-versus-placebo-to-treat-early-rheumatoid-arthritis-on-mri-103371https://curecurrent.com/trials/a-study-comparing-infusion-rates-of-tocilizumab-in-patients-with-moderate-to-severe-rheumatoid-arthritis-103372https://curecurrent.com/trials/a-trial-to-investigate-the-safety-tolerability-pharmacokinetics-and-pharmacodynamics-of-nnc0215-0384-administered-to-sub-103373https://curecurrent.com/trials/home-based-computer-gaming-hand-exercise-regimen-for-people-with-arthritis-affecting-the-hands-103374https://curecurrent.com/trials/an-extension-study-of-tocilizumab-myeloma-receptor-antibody-mra-in-patients-completing-treatment-in-tocilizumab-core-stu-103375https://curecurrent.com/trials/efficacy-and-safety-of-biil-284-bs-in-adult-patients-with-active-rheumatoid-arthritis-103376https://curecurrent.com/trials/a-study-of-cp-195543-and-celecoxib-dual-therapy-in-subjects-with-rheumatoid-arthritis-103377https://curecurrent.com/trials/a-study-of-roactemra-actemra-tocilizumab-in-adult-patients-with-rheumatoid-arthritis-svoboda-programme-103378https://curecurrent.com/trials/pharmacokinetics-safety-and-efficacy-of-biil-284-bs-in-patients-with-rheumatoid-arthritis-ra-103379https://curecurrent.com/trials/torpedo-study-a-study-on-rapid-effect-of-tocilizumab-in-patients-with-rheumatoid-arthritis-with-an-inadequate-response-t-103380https://curecurrent.com/trials/immunogenicity-and-safety-of-tnfa-kinoid-in-rheumatoid-arthritis-with-secondary-resistance-to-tnfa-antagonists-103381https://curecurrent.com/trials/study-of-two-different-starting-doses-of-methotrexate-when-starting-treatment-in-rheumatoid-arthritis-103382https://curecurrent.com/trials/smart-study-a-study-of-re-treatment-with-mabthera-rituximab-in-patients-with-rheumatoid-arthritis-who-have-failed-on-ant-103383https://curecurrent.com/trials/short-term-follow-up-of-patient-implanted-with-the-metatarso-phalangeal-prosthesis-metis-103384https://curecurrent.com/trials/ra-denosumab-on-bone-microstructure-study-103385https://curecurrent.com/trials/the-use-of-neuromuscular-electrical-stimulation-to-reverse-muscle-atrophy-in-patients-with-rheumatoid-arthritis-103386https://curecurrent.com/trials/a-study-of-the-safety-and-efficacy-of-golimumab-in-subjects-with-rheumatoid-arthritis-that-are-methotrexate-naive-103387https://curecurrent.com/trials/rheumatology-informatics-system-for-effectiveness-103388https://curecurrent.com/trials/hydroxychloroquine-to-improve-insulin-sensitivity-in-rheumatoid-arthritis-103389https://curecurrent.com/trials/the-controlled-trial-of-apremilast-for-rheumatoid-arthritis-treatment-carat-103390https://curecurrent.com/trials/benefit-of-orthopedic-navigation-in-the-arthroplasty-of-the-hip-103391https://curecurrent.com/trials/rheumatology-clinical-registry-103392https://curecurrent.com/trials/monitoring-epstein-barr-virus-ebv-load-in-rheumatoid-arthritis-patients-treated-with-new-immunosuppressive-drugs-103393https://curecurrent.com/trials/a-double-blind-placebo-controlled-study-to-assess-the-efficacy-on-joint-damage-in-ra-patients-103394https://curecurrent.com/trials/ascension-humeral-resurfacing-arthroplasty-follow-up-study-103395https://curecurrent.com/trials/a-trial-investigating-the-mechanism-of-action-of-nnc0109-0012-anti-il-20-mab-through-synovial-biopsies-in-subjects-with-103396https://curecurrent.com/trials/a-study-of-tocilizumab-with-or-without-methotrexate-in-patients-with-rheumatoid-arthritis-103397https://curecurrent.com/trials/efficacy-safety-and-pharmacokinetics-of-birb-796-bs-tablets-in-patients-with-active-rheumatoid-arthritis-103398https://curecurrent.com/trials/an-extension-to-study-ma21573-evaluating-tocilizumab-in-patients-with-active-rheumatoid-arthritis-and-an-inadequate-resp-103399https://curecurrent.com/trials/efficacy-and-safety-of-different-doses-of-birb-796-bs-in-patients-with-active-rheumatoid-arthritis-103400https://curecurrent.com/trials/study-to-assess-the-safety-and-efficacy-of-etanercept-in-patients-treated-over-the-long-term-in-real-world-clinical-prac-103401https://curecurrent.com/trials/a-study-of-mabthera-rituximab-in-combination-with-methotrexate-in-patients-with-rheumatoid-arthritis-who-have-had-an-ina-103402https://curecurrent.com/trials/observational-trial-with-enbrel-103403https://curecurrent.com/trials/safety-and-efficacy-of-measles-mumps-rubella-vaccination-in-juvenile-idiopathic-arthritis-103404https://curecurrent.com/trials/a-study-of-safety-and-effectiveness-of-golimumab-in-participants-with-active-rheumatoid-arthritis-despite-methotrexate-t-103405https://curecurrent.com/trials/clinical-study-evaluating-an-acetabular-cup-system-after-total-hip-replacement-103406https://curecurrent.com/trials/health-outcomes-in-rheumatoid-arthritis-in-greece-103407https://curecurrent.com/trials/cameo-canadian-methotrexate-and-etanercept-outcome-study-103408https://curecurrent.com/trials/a-study-of-tocilizumab-as-monotherapy-or-in-combination-with-dmards-in-patients-with-moderate-to-severe-active-rheumatoi-103409https://curecurrent.com/trials/digitized-grip-strength-103410https://curecurrent.com/trials/effect-of-moderate-to-high-intensity-aerobic-interval-training-on-polysomnographic-measured-sleep-in-patients-with-rheum-103411https://curecurrent.com/trials/a-study-of-tocilizumab-and-methotrexate-treatment-strategies-adding-tocilizumab-to-methotrexate-versus-switching-to-toci-103412https://curecurrent.com/trials/study-evaluating-etanercept-plus-methotrexate-in-early-rheumatoid-arthritis-103413https://curecurrent.com/trials/treatment-of-early-aggressive-rheumatoid-arthritis-tear-103414https://curecurrent.com/trials/a-pharmacokinetic-and-pharmacodynamic-study-of-mabthera-rituximab-plus-methotrexate-in-patients-with-rheumatoid-arthriti-103415https://curecurrent.com/trials/randomized-double-blind-parallel-trial-to-evaluate-equivalence-in-efficacy-and-safety-of-hd203-and-enbrel-in-ra-patients-103416https://curecurrent.com/trials/a-study-of-roactemra-actemra-tocilizumab-in-patients-with-active-rheumatoid-arthritis-who-have-an-inadequate-response-to-103417https://curecurrent.com/trials/safety-and-efficacy-of-mobic-ampoules-in-the-initiation-of-treatment-of-painful-exacerbations-of-osteoarthritis-rheumato-103418https://curecurrent.com/trials/observational-study-of-meloxicam-in-mexican-patients-with-rheumatic-diseases-103419https://curecurrent.com/trials/a-randomized-parallel-group-comparison-study-of-topical-corticosteroids-in-dry-eye-patients-with-sj-gren-syndrome-103420https://curecurrent.com/trials/safety-and-efficacy-of-meloxicam-compared-to-other-nonsteroidal-antiinflammatory-drugs-nsaids-in-an-observational-cohort-103421https://curecurrent.com/trials/randomised-double-blind-placebo-controlled-parallel-group-study-in-patients-with-active-rheumatoid-arthritis-magnetic-re-103422https://curecurrent.com/trials/open-label-multicenter-extension-study-for-patients-completing-treatment-phase-of-a-rigel-sponsored-r935788-studies-103423https://curecurrent.com/trials/study-evaluating-the-efficacy-of-thick-shell-mussel-lipid-extract-in-chinese-subjects-with-rheumatoid-arthritis-103424https://curecurrent.com/trials/a-dose-escalation-study-to-assess-safety-tolerability-and-pharmacokinetics-of-asp2409-following-a-single-intravenous-dos-103425https://curecurrent.com/trials/a-study-in-rheumatoid-arthritis-ra-patients-to-compare-two-formulations-of-adalimumab-for-pharmacokinetic-pharmacodynami-103426https://curecurrent.com/trials/a-study-of-mabthera-rituximab-in-patients-with-rheumatoid-arthritis-who-have-had-an-inadequate-response-to-methotrexate-103427https://curecurrent.com/trials/investigating-clinical-efficacy-of-ofatumumab-in-adult-rheumatoid-arthritis-ra-patients-who-had-an-inadequate-response-t-103428https://curecurrent.com/trials/can-tnf-alpha-incomplete-secondary-responders-attain-a-safe-and-efficacious-response-switching-to-cimzia-103429https://curecurrent.com/trials/study-of-kb003-in-biologics-inadequate-rheumatoid-arthritis-103430https://curecurrent.com/trials/biomarkers-of-anti-tnf-therapy-efficacy-in-rheumatoid-arthritis-to-define-unresponsive-patients-103431https://curecurrent.com/trials/a-study-of-roactemra-actemra-tocilizumab-in-combination-with-methotrexate-in-patients-with-active-rheumatoid-arthritis-w-103432https://curecurrent.com/trials/a-study-to-evaluate-a-single-intravenous-iv-dose-using-a-new-manufactured-clone-and-single-ascending-doses-of-subcutaneo-103433https://curecurrent.com/trials/safety-and-effectiveness-study-of-rwj-445380-cathepsin-s-inhibitor-in-patients-with-active-rheumatoid-arthritis-despite-103434https://curecurrent.com/trials/a-study-comparing-crx-102-plus-disease-modifying-anti-rheumatic-drug-dmard-therapy-to-placebo-plus-dmard-therapy-in-ra-103435https://curecurrent.com/trials/comparison-of-methotrexate-mtx-and-the-vibex-mtx-device-103436https://curecurrent.com/trials/a-phase-ii-trial-comparing-z-102-with-placebo-in-patients-with-moderate-to-severe-rheumatoid-arthritis-103437https://curecurrent.com/trials/primary-tka-cruciate-retaining-vs-cruciate-substituting-with-rotating-platform-knee-prostheses-103438https://curecurrent.com/trials/a-study-of-two-doses-of-mrc375-in-moderate-to-severe-rheumatoid-arthritis-patients-103439https://curecurrent.com/trials/effectiveness-and-safety-of-adalimumab-in-rheumatoid-arthritis-patients-in-routine-clinical-practice-103440https://curecurrent.com/trials/study-of-the-effect-of-fostamatinib-twice-daily-on-blood-pressure-in-patients-with-rheumatoid-arthritis-103441https://curecurrent.com/trials/cross-sectional-study-of-use-of-speckle-method-in-early-diagnosis-of-cardiovascular-dysfunction-103442https://curecurrent.com/trials/efficacy-of-physiotherapy-on-the-health-and-quality-of-life-of-the-rheumatic-patient-103443https://curecurrent.com/trials/evaluation-of-efficacy-and-safety-of-fostamatinib-monotherapy-compared-with-adalimumab-monotherapy-in-patients-with-rheu-103444https://curecurrent.com/trials/anterior-shoulder-us-a-new-access-103445https://curecurrent.com/trials/a-study-of-rheumatoid-arthritis-patients-on-adalimumab-to-evaluate-quality-of-life-variables-effects-on-work-productivit-103446https://curecurrent.com/trials/interruption-of-tnfinhibitors-and-endothelial-function-103447https://curecurrent.com/trials/total-knee-replacement-with-the-rocc-knee-103448https://curecurrent.com/trials/actual-human-use-of-methotrexate-mtx-subcutaneously-administered-via-the-vibex-mtx-auto-injector-device-103449https://curecurrent.com/trials/an-efficacy-and-safety-study-of-golimumab-in-patients-with-active-rheumatoid-arthritis-despite-methotrexate-therapy-103450https://curecurrent.com/trials/multicenter-study-to-evaluate-crx-102-vs-each-of-its-components-to-treat-active-rheumatoid-arthritis-103451https://curecurrent.com/trials/efficacy-and-safety-of-adalimumab-in-patients-with-rheumatoid-arthritis-in-routine-clinical-practice-103452https://curecurrent.com/trials/clinical-performance-evaluation-of-fyodor-urine-malaria-test-umt-103453https://curecurrent.com/trials/evaluation-of-effectiveness-of-two-dosing-regimens-of-fostamatinib-compared-to-placebo-in-patients-with-rheumatoid-arthr-103454https://curecurrent.com/trials/impact-of-subcutaneous-abatacept-in-rheumatoid-arthritis-assessing-inhibition-of-structural-damage-103455https://curecurrent.com/trials/an-observational-study-of-lymphoma-in-patients-with-rheumatoid-arthritis-or-crohn-s-disease-103456https://curecurrent.com/trials/dataglove-to-measure-joint-stiffness-in-patients-with-arthritis-103457https://curecurrent.com/trials/a-study-of-jnj-40346527-in-patients-with-active-rheumatoid-arthritis-despite-disease-modifying-antirheumatic-drug-therap-103458https://curecurrent.com/trials/study-to-assess-steady-state-trough-concentrations-safety-and-immunogenicity-of-abatacept-after-subcutaneous-sc-administ-103459https://curecurrent.com/trials/rheumatoid-arthritis-treatment-and-biopsy-study-assessing-certolizumab-pegol-cimzia-103460https://curecurrent.com/trials/evaluation-of-effectiveness-of-two-dosing-regimens-of-fostamatinib-compared-to-placebo-in-patients-with-rheumatoid-arthr-103461https://curecurrent.com/trials/evaluation-of-effectiveness-of-two-dosing-regimens-of-fostamatinib-compared-to-placebo-in-patients-with-rheumatoid-arthr-103462https://curecurrent.com/trials/evaluation-of-safety-and-effectiveness-of-fostamatinib-compared-to-placebo-in-patients-in-asia-with-rheumatoid-arthritis-103463https://curecurrent.com/trials/evaluation-of-long-term-safety-and-effectiveness-of-fostamatinib-in-the-treatment-of-rheumatoid-arthritis-ra-103464https://curecurrent.com/trials/a-study-to-evaluate-the-effect-of-cp-690-550-on-measures-of-kidney-function-in-patients-with-active-rheumatoid-arthritis-103465https://curecurrent.com/trials/a-long-term-study-to-assess-the-safety-of-fostamatinib-in-patients-in-asia-with-rheumatoid-arthritis-103466https://curecurrent.com/trials/a-study-of-efficacy-of-rituximab-mabthera-rituxan-in-patients-with-rheumatoid-arthritis-using-magnetic-resonance-imaging-103467https://curecurrent.com/trials/comparison-between-dead-sea-solar-and-water-treatment-to-sulfur-pool-and-medicinal-mud-treatment-in-patients-with-ra-103468https://curecurrent.com/trials/assessment-of-pain-management-in-rheumatoid-arthritis-psoriatic-arthritis-and-ankylosing-spondylitis-patients-who-are-ab-103469https://curecurrent.com/trials/pharmacokinetic-study-to-compare-the-blood-levels-of-abatacept-manufactured-at-lonza-biologics-to-the-blood-levels-of-ab-103470https://curecurrent.com/trials/health-related-quality-of-life-and-patient-reported-outcomes-in-rheumatoid-arthritis-patients-treated-with-certolizumab-103471https://curecurrent.com/trials/a-long-term-safety-study-of-infliximab-remicade-103472https://curecurrent.com/trials/a-study-to-determine-the-effect-of-methotrexate-mtx-dose-on-clinical-outcome-and-ultrasonographic-signs-in-subjects-with-103473https://curecurrent.com/trials/atherosclerosis-in-rheumatoid-arthritis-103474https://curecurrent.com/trials/magnetic-resonance-image-verified-early-response-to-certolizumab-pegol-in-subjects-with-active-rheumatoid-arthritis-ra-103475https://curecurrent.com/trials/a-study-of-rheumatoid-arthritis-treatment-with-enbrel-in-adult-patient-in-outpatient-department-103476https://curecurrent.com/trials/a-post-marketing-observational-study-to-evaluate-the-effectiveness-of-adalimumab-in-patients-with-moderately-to-severely-103477https://curecurrent.com/trials/interleukin-1-trap-to-treat-autoinflammatory-diseases-103478https://curecurrent.com/trials/vascular-occlusion-and-rheumatoid-arthritis-103479https://curecurrent.com/trials/a-study-of-the-safety-and-efficacy-of-golimumab-cnto-148-in-subjects-with-active-rheumatoid-arthritis-previously-treated-103480https://curecurrent.com/trials/exposure-study-comparing-3-routes-of-methotrexate-mtx-administration-103481https://curecurrent.com/trials/a-crossover-study-of-the-safety-and-tolerability-of-two-formulations-of-adalimumab-103482https://curecurrent.com/trials/quality-of-life-in-chronic-arthritis-103483https://curecurrent.com/trials/crossover-study-of-safety-and-tolerability-of-two-formulations-of-adalimumab-103484https://curecurrent.com/trials/fatigue-in-rheumatoid-arthritis-longitudinal-study-103485https://curecurrent.com/trials/determine-the-improvement-in-activity-status-quality-of-life-qol-of-patients-with-rheumatoid-arthritis-ra-during-treatme-103486https://curecurrent.com/trials/efficacy-safety-and-tolerability-of-acz885-in-patients-with-active-rheumatoid-arthritis-103487https://curecurrent.com/trials/a-study-of-roactemra-actemra-tocilizumab-versus-adalimumab-in-combination-with-methotrexate-mtx-in-patients-with-moderat-103488https://curecurrent.com/trials/study-of-different-doses-of-folic-acid-in-combination-with-methotrexate-in-rheumatoid-arthritis-103489https://curecurrent.com/trials/a-study-to-evaluate-the-pharmacokinetics-pharmacodynamics-safety-and-tolerability-of-asp2408-after-multiple-dose-subcuta-103490https://curecurrent.com/trials/efficacy-pharmacokinetics-safety-and-immunogenicity-study-of-abatacept-administered-subcutaneously-to-treat-rheumatoid-a-103491https://curecurrent.com/trials/a-study-to-assess-the-effect-of-tocilizumab-methotrexate-on-prevention-of-structural-joint-damage-in-patients-with-moder-103492https://curecurrent.com/trials/a-randomized-double-blind-placebo-controlled-clinical-study-of-the-oral-il-12-23-inhibitor-sta-5326-mesylate-administere-103493https://curecurrent.com/trials/abatacept-versus-adalimumab-head-to-head-103494https://curecurrent.com/trials/follow-up-of-rheumatoid-arthritis-ra-moderate-to-low-disease-activity-study-103495https://curecurrent.com/trials/a-new-oral-salivary-equivalent-compared-to-two-moisturizing-mouth-sprays-in-patients-with-xerostomia-niagara-study-103496https://curecurrent.com/trials/single-ascending-dose-study-of-safety-and-tolerability-of-sarilumab-and-methotrexate-in-japanese-patients-with-rheumatoi-103497https://curecurrent.com/trials/relaxation-response-training-for-the-treatment-of-rheumatoid-arthritis-103498https://curecurrent.com/trials/lifestyle-interventions-based-on-the-mediterranean-diet-for-patients-with-rheumatoid-arthritis-103499https://curecurrent.com/trials/an-effectiveness-and-safety-study-of-intravenous-golimumab-in-patients-with-active-rheumatoid-arthritis-despite-treatmen-103500https://curecurrent.com/trials/impact-of-literacy-level-on-patient-education-and-health-among-people-with-arthritis-103501https://curecurrent.com/trials/peak-study-physical-exercise-and-activity-in-kids-103502https://curecurrent.com/trials/a-pilot-study-of-the-feasibility-of-discontinuation-of-adalimumab-in-stable-rheumatoid-arthritis-patients-in-clinical-re-103503https://curecurrent.com/trials/study-of-the-treatment-of-algerian-patients-with-early-rheumatoid-arthritis-103504https://curecurrent.com/trials/foot-orthoses-fos-on-pain-quality-of-life-and-the-gait-with-children-diagnosed-with-jia-103505https://curecurrent.com/trials/rheumatoid-arthritis-comparison-of-active-therapies-in-patients-with-active-disease-despite-methotrexate-therapy-103506https://curecurrent.com/trials/study-evaluating-the-efficacy-and-safety-of-sbi-087-in-seropositive-subjects-with-active-rheumatoid-arthritis-103507https://curecurrent.com/trials/a-long-term-extension-study-of-tocilizumab-myeloma-receptor-antibody-mra-in-patients-with-rheumatoid-arthritis-103508https://curecurrent.com/trials/group-training-and-quality-of-life-and-reduction-of-pain-in-rheumatoid-arthritis-patients-103509https://curecurrent.com/trials/effect-of-fish-oil-on-surgery-pain-after-knee-replacement-patients-randomized-prospective-double-blind-placebo-control-t-103510https://curecurrent.com/trials/endothelial-function-inflammatory-disease-activity-and-bone-and-cartilage-markers-in-rheumatic-patients-the-influence-of-103511https://curecurrent.com/trials/to-evaluate-1-year-extension-study-of-the-efficacy-and-safety-of-tocilizumab-in-patients-with-moderate-to-severe-rheumat-103512https://curecurrent.com/trials/study-to-determine-the-effects-of-different-doses-of-methotrexate-mtx-when-taken-with-adalimumab-in-subjects-with-early-103513https://curecurrent.com/trials/effect-of-tocilizumab-to-the-cellular-immune-response-to-influenza-vaccine-103514https://curecurrent.com/trials/improving-motivation-for-physical-activity-in-arthritis-clinical-trial-103515https://curecurrent.com/trials/sb-681323-in-subjects-with-rheumatoid-arthritis-103516https://curecurrent.com/trials/a-one-year-double-blind-trial-to-investigate-the-efficacy-and-safety-of-meloxicam-oral-suspension-in-juvenile-rheumatoid-103517https://curecurrent.com/trials/safety-and-efficacy-of-mobic-inj-meloxicam-for-the-patients-with-oa-or-ra-observational-study-103518https://curecurrent.com/trials/a-multi-center-trial-to-compare-three-doses-of-meloxicam-and-placebo-in-patients-with-rheumatoid-arthritis-103519https://curecurrent.com/trials/meloxicam-mobic-in-juvenile-rheumatoid-arthritis-jra-103520https://curecurrent.com/trials/a-6-months-infliximab-or-placebo-study-in-ua-at-high-risk-of-ra-clinical-radiological-and-synovial-benefit-103521https://curecurrent.com/trials/study-of-the-response-and-cardiorespiratory-endurance-in-early-ra-patients-treated-with-tocilizumab-or-methotrexate-103522https://curecurrent.com/trials/characterize-patients-with-moderately-active-rheumatoid-arthritis-ra-103523https://curecurrent.com/trials/an-observational-study-of-infliximab-injection-in-ankylosing-spondylitis-rheumatoid-arthritis-psoriatic-arthritis-and-ps-103524https://curecurrent.com/trials/a-study-of-retreatment-with-rituximab-in-patients-with-rheumatoid-arthritis-receiving-background-methotrexate-103525https://curecurrent.com/trials/hydroxychloroquine-treatment-of-dry-eyes-in-patients-with-primary-sj-gren-s-syndrome-103526https://curecurrent.com/trials/safety-study-of-a-single-dose-of-regn88-sar153191-in-patients-with-rheumatoid-arthritis-103527https://curecurrent.com/trials/a-multiple-dose-study-of-the-safety-and-tolerability-of-regn88-sar153191-in-rheumatoid-arthritis-subjects-103528https://curecurrent.com/trials/a-safety-and-tolerability-study-of-regn88-sar153191-in-subjects-with-rheumatoid-arthritis-103529https://curecurrent.com/trials/a-3-year-study-following-up-patients-with-moderate-to-severe-rheumatoid-arthritis-treated-with-humira-in-greece-103530https://curecurrent.com/trials/dynamic-contrast-enhanced-magnetic-resonance-imaging-dce-mri-to-measure-response-to-etanercept-in-rheumatoid-arthritis-103531https://curecurrent.com/trials/biib023-anti-tweak-in-subjects-with-rheumatoid-arthritis-103532https://curecurrent.com/trials/biib057-in-subjects-with-rheumatoid-arthritis-and-inadequate-response-to-disease-modifying-antirheumatic-drugs-103533https://curecurrent.com/trials/efficacy-and-safety-study-of-bg00012-with-methotrexate-in-patients-with-active-rheumatoid-arthritis-103534https://curecurrent.com/trials/an-efficacy-and-safety-study-of-infliximab-in-participants-with-rheumatoid-arthritis-103535https://curecurrent.com/trials/restart-c0168z05-rheumatoid-arthritis-study-103536https://curecurrent.com/trials/study-comparing-the-effect-on-disease-activity-when-reducing-or-discontinuing-etanercept-in-subjects-with-ra-103537https://curecurrent.com/trials/study-of-subcutaneous-golimumab-in-chinese-patients-with-active-rheumatoid-arthritis-despite-methotrexate-therapy-103538https://curecurrent.com/trials/efficacy-and-safety-of-cdp870-versus-placebo-in-the-treatment-of-the-signs-and-symptoms-of-rheumatoid-arthritis-103539https://curecurrent.com/trials/efficacy-and-safety-of-cdp870-and-methotrexate-compared-to-methotrexate-alone-in-subjects-with-rheumatoid-arthritis-103540https://curecurrent.com/trials/study-evaluating-multiple-ascending-doses-of-atn-103-in-japanese-subjects-with-rheumatoid-arthritis-103541https://curecurrent.com/trials/impact-of-rituximab-on-mri-evidence-of-disease-activity-in-patients-with-moderate-to-severe-rheumatoid-arthritis-103542https://curecurrent.com/trials/standard-disease-activity-parameters-and-step-activity-in-patients-with-rheumatoid-arthritis-receiving-etanercept-103543https://curecurrent.com/trials/surveillance-of-humira-injection-in-korean-patients-103544https://curecurrent.com/trials/a-study-on-the-prevalence-of-the-modified-citrullinated-vimentin-anti-body-anti-mcv-in-an-irish-rheumatoid-arthritis-ra-103545https://curecurrent.com/trials/a-drug-use-investigation-of-enbrel-for-post-marketing-surveillance-pms-for-ra-and-psa-103546https://curecurrent.com/trials/pain-and-stress-management-for-people-with-rheumatoid-arthritis-103547https://curecurrent.com/trials/clinical-investigation-of-the-lcs-complete-posterior-stabilized-mobile-bearing-total-knee-system-103548https://curecurrent.com/trials/a-safety-and-efficacy-study-of-lymphostat-b-monoclonal-anti-blys-antibody-in-subjects-with-rheumatoid-arthritis-ra-103549https://curecurrent.com/trials/a-retrospective-observational-study-of-roactemra-actemra-tocilizumab-in-clinical-practice-in-patients-with-rheumatoid-ar-103550https://curecurrent.com/trials/study-of-mra-in-patients-with-rheumatoid-arthritis-ra-103551https://curecurrent.com/trials/long-term-treatment-study-of-mra-for-rheumatoid-arthritis-ra-from-study-mra220jp-or-mra221jp-103552https://curecurrent.com/trials/long-term-treatment-study-of-mra-for-rheumatoid-arthritis-ra-from-study-mra012jp-103553https://curecurrent.com/trials/phase-3-study-of-pelubiprofen-tab-celebrex-cap-in-rheumatoid-arthritis-patients-103554https://curecurrent.com/trials/a-phase-iii-study-of-abatacept-in-patients-with-rheumatoid-arthritis-and-an-inadequate-response-to-methotrexate-103555https://curecurrent.com/trials/a-continuation-trial-for-subjects-with-rheumatoid-arthritis-that-have-completed-protocol-lbra01-103556https://curecurrent.com/trials/efficacy-and-safety-of-tripterygium-wilfordii-in-patients-with-rheumatoid-arthritis-103557https://curecurrent.com/trials/infliximab-and-classic-dmards-in-the-rheumatoid-arthritis-patients-103558https://curecurrent.com/trials/a-safety-and-efficacy-of-homeopathic-medicine-rhus-toxicodendron-30-in-the-treatment-of-rheumatoid-arthritis-103559https://curecurrent.com/trials/calcium-supplements-for-bone-health-in-juvenile-rheumatoid-arthritis-103560https://curecurrent.com/trials/a-study-to-evaluate-biomarkers-in-blood-samples-in-subjects-with-rheumatoid-arthritis-103561https://curecurrent.com/trials/preference-methotrexate-mtx-pre-filled-syringe-versus-pre-filled-pen-in-rheumatoid-arthritis-ra-103562https://curecurrent.com/trials/efficacy-and-safety-of-adalimumab-and-methotrexate-mtx-versus-mtx-monotherapy-in-subjects-with-early-rheumatoid-arthriti-103563https://curecurrent.com/trials/a-study-of-the-effect-of-supervised-exercise-programme-in-patients-with-rheumatoid-arthritis-103564https://curecurrent.com/trials/human-tumor-necrosis-factor-alpha-tnfa-induced-pre-b-cell-bone-marrow-emigrants-103565https://curecurrent.com/trials/a-rheumatoid-arthritis-study-to-assess-early-response-to-abatacept-mtx-as-defined-by-improvement-of-synovitis-measures-b-103566https://curecurrent.com/trials/dose-ranging-study-with-glpg0634-in-methotrexate-refractory-active-rheumatoid-arthritis-patients-103567https://curecurrent.com/trials/safety-and-efficacy-study-of-umbilical-cord-derived-mesenchymal-stem-cells-for-rheumatoid-arthritis-103568https://curecurrent.com/trials/gene-expression-profiling-in-pbmcs-as-a-tool-for-prediction-of-infliximab-responsiveness-in-rheumatoid-arthritis-103569https://curecurrent.com/trials/a-phase-iii-study-of-abatacept-in-japanese-subjects-with-rheumatoid-arthritis-103570https://curecurrent.com/trials/patient-education-in-rheumatoid-arthritis-and-osteoarthritis-103571https://curecurrent.com/trials/study-of-ni-071-in-comparison-with-remicade-in-patients-with-rheumatoid-arthritis-103572https://curecurrent.com/trials/low-density-lipoprotein-cholesterol-cldl-as-a-cardiovascular-disease-risk-factor-in-rheumatoid-arthritis-103573https://curecurrent.com/trials/transplantation-of-bone-marrow-derived-mesenchymal-stem-cells-in-affected-knee-osteoarthritis-by-rheumatoid-arthritis-103574https://curecurrent.com/trials/investigating-the-impact-of-mode-of-administration-on-item-response-103575https://curecurrent.com/trials/comparison-of-three-different-treatment-regimes-in-early-rheumatoid-arthritis-a-randomized-open-labelled-trial-103576https://curecurrent.com/trials/trial-of-early-aggressive-drug-therapy-in-juvenile-idiopathic-arthritis-103577https://curecurrent.com/trials/evaluating-efficacy-and-safety-of-etanercept-50-mg-twice-weekly-biw-in-rheumatoid-arthritis-ra-subjects-who-are-sub-opti-103578https://curecurrent.com/trials/oral-collagen-for-rheumatoid-arthritis-103579https://curecurrent.com/trials/a-safety-and-efficacy-study-of-golimumab-cnto-148-in-patients-with-active-rheumatoid-arthritis-despite-methotrexate-ther-103580https://curecurrent.com/trials/study-of-the-safety-of-mdx-1342-in-combination-with-methotrexate-in-patients-with-rheumatoid-arthritis-103581https://curecurrent.com/trials/safety-tolerability-and-pharmacodynamic-study-of-isis-crp-rx-in-rheumatoid-arthritis-103582https://curecurrent.com/trials/cognitive-behavioral-therapy-treatments-for-adults-with-rheumatoid-arthritis-the-sara-study-103583https://curecurrent.com/trials/prevalence-study-of-gastrointestinal-risk-factors-in-patients-with-osteoarthritis-oa-rheumatoid-arthritis-ra-and-ankylos-103584https://curecurrent.com/trials/comparison-of-rotating-vs-fixed-platform-of-the-columbus-knee-prosthesis-103585https://curecurrent.com/trials/open-label-extension-treatment-with-etanercept-tnfr-fc-for-participating-patients-in-etanercept-tnfr-fc-clinical-trial-0-103586https://curecurrent.com/trials/registry-of-etanercept-enbrel-in-children-with-juvenile-rheumatoid-arthritis-103587https://curecurrent.com/trials/effectiveness-intraarticular-corticosteroid-103588https://curecurrent.com/trials/treatment-of-dry-eye-using-0-03-tacrolimus-eye-drops-103589https://curecurrent.com/trials/study-to-assess-the-efficacy-and-safety-of-rituximab-in-patients-with-rheumatoid-arthritis-103590https://curecurrent.com/trials/exploratory-trial-to-evaluate-premature-endothelial-dysfunction-in-early-rheumatoid-arthritis-ra-compared-to-patients-wi-103591https://curecurrent.com/trials/a-study-to-investigate-how-jnj-38518168-may-affect-the-plasma-levels-of-methotrexate-in-rheumatoid-arthritis-participant-103592https://curecurrent.com/trials/initial-validation-of-promis-physical-function-disability-scales-in-rheumatoid-arthritis-ra-103593https://curecurrent.com/trials/healthier-living-with-arthritis-online-program-103594https://curecurrent.com/trials/treatment-for-subjects-with-active-rheumatoid-arthritis-ra-103595https://curecurrent.com/trials/an-efficacy-and-safety-study-of-jnj-38518168-in-adult-participants-with-rheumatoid-arthritis-103596https://curecurrent.com/trials/evaluation-effects-of-treatment-with-il-6r-inhibitor-on-clinical-response-and-biomarkers-in-patients-with-rheumatoid-art-103597https://curecurrent.com/trials/neurotrophins-implications-in-primary-sj-gren-syndrome-103598https://curecurrent.com/trials/a-study-to-assess-ch1504-in-patients-with-active-rheumatoid-arthritis-103599https://curecurrent.com/trials/a-study-of-ch-4051-in-patients-with-rheumatoid-arthritis-ra-103600https://curecurrent.com/trials/stem-cell-support-in-patients-with-rheumatoid-arthritis-103601https://curecurrent.com/trials/impact-of-ra-therapy-compliance-on-patient-reported-outcomes-103602https://curecurrent.com/trials/extension-study-of-tocilizumab-long-term-treatment-of-moderate-to-severe-rheumatoid-arthritis-patients-103603https://curecurrent.com/trials/glatiramer-acetate-for-multiple-sclerosis-with-autoimmune-comorbidities-103604https://curecurrent.com/trials/cognitive-behavioral-therapy-and-tai-chi-chih-for-patients-with-rheumatoid-arthritis-103605https://curecurrent.com/trials/a-study-of-tocilizumab-in-combination-with-an-oral-contraceptive-in-patients-with-rheumatoid-arthritis-103606https://curecurrent.com/trials/a-study-to-assess-the-immune-response-following-administration-of-influenza-and-pneumococcal-vaccines-to-subjects-with-r-103607https://curecurrent.com/trials/study-comparing-perceptions-and-satisfaction-for-two-different-delivery-mechanisms-for-etanercept-103608https://curecurrent.com/trials/efficacy-and-safety-of-olokizumab-with-rheumatoid-arthritis-with-previously-failed-to-anti-tumor-necrosis-factor-anti-tn-103609https://curecurrent.com/trials/comparison-of-5-cp-690-550-doses-vs-placebo-for-the-treatment-of-rheumatoid-arthritis-in-japan-103610https://curecurrent.com/trials/comparing-tai-chi-chih-and-relaxation-therapy-in-the-treatment-of-rheumatoid-arthritis-103611https://curecurrent.com/trials/safety-tolerability-and-efficacy-study-of-the-new-medication-ask8007-to-treat-patients-with-rheumatoid-arthritis-103612https://curecurrent.com/trials/a-study-to-determine-the-number-of-participants-with-rheumatoid-arthritis-ra-who-meet-the-requirements-for-treatment-wit-103613https://curecurrent.com/trials/a-study-to-investigate-how-jnj-39758979-may-affect-the-plasma-levels-of-methotrexate-in-rheumatoid-arthritis-participant-103614https://curecurrent.com/trials/program-evaluating-the-autoimmune-disease-investigational-drug-ct-p13-in-ra-patients-planetra-103615https://curecurrent.com/trials/study-evaluating-2-dosing-regimens-of-tru-015-in-rheumatoid-arthritis-103616https://curecurrent.com/trials/study-comparing-enbrel-etanercept-plus-methotrexate-versus-enbrel-alone-in-active-rheumatoid-arthritis-despite-current-m-103617https://curecurrent.com/trials/rituximab-for-the-treatment-of-early-rheumatoid-arthritis-ra-103618https://curecurrent.com/trials/evaluation-of-humira-in-patients-with-active-rheumatoid-arthritis-psoriatic-arthritis-and-ankylosing-spondylitis-in-east-103619https://curecurrent.com/trials/genetics-and-mechanisms-of-rheumatoid-arthritis-103620https://curecurrent.com/trials/a-study-of-tocilizumab-roactemra-actemra-versus-adalimumab-in-patients-with-rheumatoid-arthritis-103621https://curecurrent.com/trials/co-administration-of-methotrexate-and-cp-690-550-103622https://curecurrent.com/trials/tumor-necrosis-factor-decreases-vitamin-d-dependant-calcium-absorption-103623https://curecurrent.com/trials/current-adoption-of-composite-indices-in-evaluating-rheumatoid-arthritis-patients-an-observational-study-103624https://curecurrent.com/trials/assess-the-pharmacokinetics-of-rosuvastatin-and-simvastatin-when-administered-alone-or-in-combination-with-fostamatinib-103625https://curecurrent.com/trials/a-6-month-randomised-double-blind-open-arm-comparator-phase-iib-with-azd9056-in-patients-with-rheumatoid-arthritis-ra-103626https://curecurrent.com/trials/validation-study-of-ra-inf-dx-a-multigene-molecular-test-used-to-predict-non-response-to-infliximab-therapy-103627https://curecurrent.com/trials/effects-of-administration-of-fostamatinib-on-blood-concentrations-of-warfarin-in-healthy-subjects-103628https://curecurrent.com/trials/three-dose-levels-of-cp-690-550-monotherapy-versus-placebo-administered-orally-twice-daily-bid-for-6-weeks-103629https://curecurrent.com/trials/study-evaluating-multiple-doses-of-atn-103-in-subjects-with-active-rheumatoid-arthritis-103630https://curecurrent.com/trials/comparison-of-4-cp-690-550-doses-vs-placebo-each-combined-with-methotrexate-for-the-treatment-of-rheumatoid-arthritis-in-103631https://curecurrent.com/trials/effects-of-cp-690-550-tasocitinib-on-cholesterol-metabolism-in-patients-with-active-rheumatoid-arthritis-103632https://curecurrent.com/trials/comparison-of-6-cp-690-550-doses-vs-placebo-each-combined-with-methotrexate-for-the-treatment-of-rheumatoid-arthritis-103633https://curecurrent.com/trials/a-phase-3-study-comparing-2-doses-of-cp-690-550-vs-placebo-for-treatment-of-rheumatoid-arthritis-103634https://curecurrent.com/trials/a-phase-3-study-comparing-2-doses-of-cp-690-550-and-the-active-comparator-humira-adalimumab-vs-placebo-for-treatment-of-103635https://curecurrent.com/trials/improving-bone-health-among-rheumatoid-arthritis-ra-patients-on-chronic-glucocorticoids-103636https://curecurrent.com/trials/remicade-infusion-management-program-103637https://curecurrent.com/trials/a-study-comparing-2-doses-of-cp-690-550-vs-placebo-for-the-treatment-of-rheumatoid-arthritis-in-patients-on-other-backgr-103638https://curecurrent.com/trials/a-study-to-evaluate-the-mechanism-of-action-of-cp-690-550-in-patients-with-rheumatoid-arthritis-103639https://curecurrent.com/trials/study-to-evaluate-and-compare-safety-and-pharmacokinetics-of-the-hcp1004-and-vimovo-500-20mg-in-healthy-korean-male-103640https://curecurrent.com/trials/a-phase-2-study-for-patients-with-a-physician-s-diagnosis-of-rheumatoid-arthritis-103641https://curecurrent.com/trials/long-term-safety-follow-up-of-subjects-previously-enrolled-in-rheumatoid-arthritis-studies-of-cp-690-550-103642https://curecurrent.com/trials/a-clinical-trial-to-study-the-effects-of-revamilast-in-patients-with-rheumatoid-arthritis-103643https://curecurrent.com/trials/agility-lp-ankle-arthroplasty-outcomes-103644https://curecurrent.com/trials/study-of-tocilizumab-in-combination-with-methotrexate-for-treatment-of-moderate-to-severe-rheumatoid-arthritis-patients-103645https://curecurrent.com/trials/a-12-week-study-of-4-doses-of-vx-509-in-subjects-with-active-rheumatoid-arthritis-103646https://curecurrent.com/trials/study-of-the-effects-of-atorvastatin-on-cholesterol-levels-in-rheumatoid-arthritis-patients-taking-cp-690-550-103647https://curecurrent.com/trials/web-based-support-to-manage-arthritis-pain-103648https://curecurrent.com/trials/a-study-of-the-effects-of-roactemra-actemra-on-vaccination-in-patients-with-rheumatoid-arthritis-on-background-methotrex-103649https://curecurrent.com/trials/study-to-characterize-demographics-compliance-tolerability-and-safety-in-patients-with-rheumatoid-arthritis-psoriatic-ar-103650https://curecurrent.com/trials/preliminary-study-of-sonic-hedgehog-signaling-pathway-in-the-pathogenesis-of-rheumatoid-arthritis-103651https://curecurrent.com/trials/humax-cd20-in-active-rheumatoid-arthritis-phase-i-ii-103652https://curecurrent.com/trials/corticosteroids-and-anti-tnf-in-methotrexate-inadequate-responder-rheumatoid-arthritis-patient-103653https://curecurrent.com/trials/single-dose-study-of-gw856553-on-a-protein-that-is-an-indicator-for-rheumatoid-arthritis-ra-103654https://curecurrent.com/trials/expanded-access-trial-of-belimumab-antibody-in-ra-patients-who-were-previously-treated-under-hgs-protocol-lbra99-103655https://curecurrent.com/trials/a-study-of-tocilizumab-in-patients-with-moderate-to-severe-active-rheumatoid-arthritis-who-have-an-inadequate-response-t-103656https://curecurrent.com/trials/effects-of-prednisolone-on-rheumatoid-arthritis-patients-103657https://curecurrent.com/trials/a-nutritional-intervention-for-arthritis-103658https://curecurrent.com/trials/an-efficacy-and-safety-study-of-cnto-148-subcutaneous-injection-compared-with-placebo-in-patients-with-active-rheumatoid-103659https://curecurrent.com/trials/flare-prevention-study-of-canakinumab-in-patients-with-active-systemic-juvenile-idiopathic-arthritis-sjia-103660https://curecurrent.com/trials/switching-anti-tnf-alpha-agents-in-rheumatoid-arthritis-ra-103661https://curecurrent.com/trials/time-to-dmard-disease-modifying-anti-rheumatic-drug-treatment-and-actual-work-limitation-of-patients-with-rheumatoid-art-103662https://curecurrent.com/trials/n-3-pufa-and-rheumatoid-arthritis-in-korea-103663https://curecurrent.com/trials/rituximab-in-rheumatoid-arthritis-lung-disease-103664https://curecurrent.com/trials/a-study-of-cdp870-as-add-on-meditation-to-methotrexate-mtx-in-patients-with-rheumatoid-arthritis-103665https://curecurrent.com/trials/retention-rates-of-adalimumab-etanercept-and-infliximab-as-first-and-second-line-biotherapy-in-patients-with-rheumatoid-103666https://curecurrent.com/trials/the-usefulness-of-interferon-release-assays-and-tuberculin-skin-test-for-detection-of-latent-tuberculosis-infection-103667https://curecurrent.com/trials/long-term-study-to-investigate-the-efficacy-safety-of-d961h-esomeprazole-for-the-prevention-of-nsaids-induced-ulcer-103668https://curecurrent.com/trials/safety-and-effectiveness-of-biological-dmards-in-elderly-patients-with-rheumatoid-arthritis-103669https://curecurrent.com/trials/long-term-safety-trial-of-z102-and-prednisone-in-patients-with-moderate-to-severe-rheumatoid-arthritis-103670https://curecurrent.com/trials/safety-efficacy-and-pharmacokinetics-of-adalimumab-in-japanese-children-with-juvenile-rheumatoid-arthritis-103671https://curecurrent.com/trials/study-comparing-etanercept-and-methotrexate-vs-methotrexate-alone-in-rheumatoid-arthritis-103672https://curecurrent.com/trials/efficacy-and-safety-of-belimumab-in-primary-sj-gren-s-syndrome-103673https://curecurrent.com/trials/joint-ultrasound-evaluation-of-asymptomatic-rheumatic-feet-103674https://curecurrent.com/trials/long-term-open-label-continuation-study-103675https://curecurrent.com/trials/drug-use-investigation-for-humira-all-patient-investigation-for-rheumatoid-arthritis-103676https://curecurrent.com/trials/a-study-of-tocilizumab-in-combination-with-dmards-in-patients-with-moderate-to-severe-rheumatoid-arthritis-103677https://curecurrent.com/trials/effectiveness-safety-and-tolerability-study-of-oxymorphone-immediate-release-ir-oral-liquid-in-opioid-tolerant-pediatric-103678https://curecurrent.com/trials/pharmacogenomics-of-anti-tnf-anti-tumor-necrosis-factor-treatment-in-patients-with-rheumatoid-arthritis-103679https://curecurrent.com/trials/safety-and-preliminary-efficacy-of-glpg0634-in-methotrexate-refractory-active-rheumatoid-arthritis-patients-103680https://curecurrent.com/trials/efficacy-confirmation-trial-of-cdp870-as-add-on-medication-to-methotrexate-mtx-in-japanese-rheumatoid-arthritis-ra-103681https://curecurrent.com/trials/a-study-of-adalimumab-in-japanese-subjects-with-rheumatoid-arthritis-103682https://curecurrent.com/trials/efficacy-confirmation-trial-of-cdp870-without-coadministration-of-methotrexate-mtx-in-japanese-rheumatoid-arthritis-ra-103683https://curecurrent.com/trials/safety-and-efficacy-of-acz885-in-adult-patients-with-established-rheumatoid-arthritis-103684https://curecurrent.com/trials/gonadotropin-releasing-hormone-gnrh-antagonist-therapy-in-rheumatoid-arthritis-103685https://curecurrent.com/trials/a-study-of-duration-of-maintained-efficacy-in-rheumatoid-arthritis-ra-patients-off-treatment-with-mra-a-development-code-103686https://curecurrent.com/trials/the-chinese-university-of-hong-kong-early-arthritis-study-103687https://curecurrent.com/trials/a-study-to-determine-the-safety-and-efficacy-of-lx3305-in-subjects-with-active-rheumatoid-arthritis-103688https://curecurrent.com/trials/safety-and-efficacy-of-intravenous-acz885-and-oral-methotrexate-therapy-in-patients-with-early-rheumatoid-arthritis-103689https://curecurrent.com/trials/study-evaluating-the-cost-of-the-treatments-of-the-refractory-psoriatic-arthritis-to-the-conventional-therapy-103690https://curecurrent.com/trials/comparison-the-safety-and-pharmacokinetic-characteristics-of-dwp422-25-mg-with-those-of-enbrel-25mg-pfs-inj-after-subcut-103691https://curecurrent.com/trials/a-single-dose-study-of-the-cam-3001-in-patients-with-rheumatoid-arthritis-103692https://curecurrent.com/trials/analysis-of-respiratory-mechanics-in-patients-with-rheumatoid-arthritis-103693https://curecurrent.com/trials/painless-synovitis-in-patients-with-longstanding-rheumatoid-arthritis-103694https://curecurrent.com/trials/efficacy-and-safety-of-belimumab-in-subjects-with-primary-sj-gren-s-syndrome-103695https://curecurrent.com/trials/a-study-to-investigate-gw274150-or-prednisolone-in-rheumatoid-arthritis-taken-repeatedly-for-28-days-103696https://curecurrent.com/trials/rituximab-induced-pulmonary-function-changes-103697https://curecurrent.com/trials/effects-of-atorvastatin-on-disease-activity-and-hdl-cholesterol-function-in-patients-with-rheumatoid-arthritis-103698https://curecurrent.com/trials/disease-modifying-antirheumatic-drugs-cycle-combination-therapy-research-103699https://curecurrent.com/trials/orofacial-evaluation-in-women-with-rheumatoid-arthritis-103700https://curecurrent.com/trials/observational-study-on-non-steroid-anti-inflammatory-drugs-nsaids-treated-patients-with-arthritic-disorder-103701https://curecurrent.com/trials/sb-681323-methotrexate-interaction-study-103702https://curecurrent.com/trials/a-study-to-look-at-the-safety-of-sb-681323-in-healthy-adult-subjects-after-intravenous-administration-of-a-single-dose-103703https://curecurrent.com/trials/abatacept-with-methotrexate-phase-iib-103704https://curecurrent.com/trials/assessment-of-nsaid-treated-patients-adherence-to-co-prescribed-proton-pump-inhibitor-ppi-103705https://curecurrent.com/trials/finding-early-rheumatoid-arthritis-103706https://curecurrent.com/trials/role-of-chemokines-and-proinflammatory-cytokines-in-rheumatoid-synovial-pathological-changes-103707https://curecurrent.com/trials/6-week-open-label-trial-with-lumiracoxib-200mg-o-d-in-primary-knee-osteoarthritis-or-rheumatoid-arthritis-103708https://curecurrent.com/trials/exercise-perceptions-and-preferences-among-rheumatoid-arthritis-patients-103709https://curecurrent.com/trials/low-dose-rituximab-as-a-first-line-biologic-therapy-for-the-treatment-of-dmard-resistant-patients-with-rheumatoid-arthri-103710https://curecurrent.com/trials/optimization-of-treatment-with-adalimumab-humira-103711https://curecurrent.com/trials/efficacy-of-aquamantys-for-reducing-transfusions-with-anterior-supine-intermuscular-approach-total-hip-arthroplasty-103712https://curecurrent.com/trials/compassionate-use-of-pennsaid-topical-lotion-diclofenac-in-osteo-or-rheumatoid-arthritis-103713https://curecurrent.com/trials/study-of-the-optimal-protocol-for-methotrexate-and-adalimumab-combination-therapy-in-early-rheumatoid-arthritis-103714https://curecurrent.com/trials/observational-real-world-evaluation-of-cost-of-infections-of-rheumatoid-arthritis-ra-patients-on-biologics-103715https://curecurrent.com/trials/phase-1b-study-of-plx5622-in-rheumatoid-arthritis-patients-who-are-receiving-methotrexate-103716https://curecurrent.com/trials/dose-escalation-with-remicade-and-orencia-103717https://curecurrent.com/trials/study-to-assess-efficacy-of-tacrolimus-methotrexate-versus-placebo-methotrexate-in-treatment-of-rheumatoid-arthritis-103718https://curecurrent.com/trials/ultrasonography-in-juvenile-idiopathic-arthritis-103719https://curecurrent.com/trials/treatment-of-tnfa-naive-patients-with-poor-prognosis-rheumatoid-arthritis-103720https://curecurrent.com/trials/rheumatoid-foot-insole-103721https://curecurrent.com/trials/a-study-of-the-safety-pharmacokinetics-and-pharmacodynamics-of-mtrx1011a-in-patients-with-rheumatoid-arthritis-103722https://curecurrent.com/trials/open-label-dose-regimen-study-evaluating-etanercept-50-mg-once-weekly-in-japanese-subjects-with-ra-103723https://curecurrent.com/trials/sc12267-4sc-101-in-combination-with-methotrexate-in-patients-with-rheumatoid-arthritis-103724https://curecurrent.com/trials/study-of-abatacept-bms-188667-in-subjects-with-active-rheumatoid-arthritis-on-background-non-biologic-dmards-disease-mod-103725https://curecurrent.com/trials/effect-of-tnf-inhibition-combined-with-conventional-dmards-on-cervical-pannus-in-patients-with-ra-and-cervical-spine-inv-103726https://curecurrent.com/trials/study-of-eszopiclone-compared-to-placebo-on-daytime-function-in-subjects-with-insomnia-related-to-rheumatoid-arthritis-103727https://curecurrent.com/trials/effects-of-administration-of-fostamatinib-on-blood-concentrations-of-an-oral-contraceptive-in-healthy-female-subjects-103728https://curecurrent.com/trials/economic-burden-in-adult-patients-diagnosed-with-rheumatoid-arthritis-ra-receiving-treatment-with-biologic-disease-modif-103729https://curecurrent.com/trials/predictors-of-the-response-to-adalimumab-in-rheumatoid-arthritis-103730https://curecurrent.com/trials/registry-of-etanercept-use-in-patients-with-rheumatoid-arthritis-in-clinical-practice-in-taiwan-103731https://curecurrent.com/trials/btt-1023-in-rheumatoid-arthritis-103732https://curecurrent.com/trials/spacing-of-tnf-blocker-injections-in-rheumatoid-arthritis-study-103733https://curecurrent.com/trials/evaluation-of-fid-114657-in-sjogren-s-syndrome-subjects-103734https://curecurrent.com/trials/atherosclerosis-in-rheumatoid-arthritis-103735https://curecurrent.com/trials/study-evaluating-enbrel-in-adults-with-active-rheumatoid-arthritis-in-luxemburg-103736https://curecurrent.com/trials/clinical-outcomes-compliance-and-effectiveness-of-switching-from-infliximab-or-etanercept-to-adalimumab-in-patients-with-103737https://curecurrent.com/trials/a-phase-iiib-study-of-bms-188667-in-subjects-with-active-rheumatoid-arthritis-and-inadequate-response-to-methotrexate-103738https://curecurrent.com/trials/rheumatoid-arthritis-ra-moderate-to-low-disease-activity-study-103739https://curecurrent.com/trials/methotrexate-inadequate-response-device-sub-study-103740https://curecurrent.com/trials/effect-of-healing-on-rheumatoid-arthritis-103741https://curecurrent.com/trials/study-of-lx3305-in-subjects-with-active-rheumatoid-arthritis-on-stable-methotrexate-103742https://curecurrent.com/trials/the-relation-between-dedicated-extremity-mri-synovitis-and-structural-deterioration-radiographic-in-patients-with-rheuma-103743https://curecurrent.com/trials/a-single-oral-dose-study-of-asp015k-in-healthy-volunteers-assessing-the-relative-bioavailability-across-three-tablet-str-103744https://curecurrent.com/trials/a-phase-iii-study-of-abatacept-bms-188667-in-patients-with-active-rheumatoid-arthritis-and-inadequate-response-to-methot-103745https://curecurrent.com/trials/a-single-oral-dose-study-to-compare-the-bioavailability-between-two-different-tablet-formulations-and-assess-if-there-is-103746https://curecurrent.com/trials/a-study-to-assess-the-receptor-occupancy-of-cd86-and-cd80-in-subjects-with-rheumatoid-arthritis-initiating-abatacept-103747https://curecurrent.com/trials/a-phase-iii-study-of-bms-188667-in-subjects-with-active-rheumatoid-arthritis-103748https://curecurrent.com/trials/a-long-term-roll-over-study-to-investigate-the-efficacy-and-safety-of-adalimumab-given-long-term-to-patients-with-rheuma-103749https://curecurrent.com/trials/articular-sonography-healthy-subjects-versus-rheumatoid-arthritis-patients-103750https://curecurrent.com/trials/phase-iii-study-of-bms-188667-ctla4ig-in-patients-with-rheumatoid-arthritis-who-are-currently-failing-anti-tnf-therapy-o-103751https://curecurrent.com/trials/a-study-on-changes-in-ifn-gamma-levels-following-anti-tnf-treatment-in-patients-undergoing-serial-quantiferon-tb-gold-in-103752https://curecurrent.com/trials/preventive-efficacy-and-safety-of-rebamipide-on-nsaid-induced-mucosal-toxicity-103753https://curecurrent.com/trials/cp-690-550-pharmacokinetics-in-healthy-chinese-subjects-103754https://curecurrent.com/trials/ultrasound-evaluation-of-hands-in-patients-with-systemic-lupus-erythematosus-103755https://curecurrent.com/trials/safety-and-effectiveness-of-adalimumab-in-patients-diagnosed-with-rheumatoid-arthritis-103756https://curecurrent.com/trials/comparison-of-the-safety-and-pharmacokinetics-of-two-sar153191-regn88-drug-products-in-rheumatoid-arthritis-patients-103757https://curecurrent.com/trials/a-study-of-tocilizumab-in-patients-with-rheumatoid-arthritis-103758https://curecurrent.com/trials/a-study-of-the-safety-and-efficacy-of-rituximab-in-patients-with-moderate-to-severe-rheumatoid-arthritis-receiving-metho-103759https://curecurrent.com/trials/pk-and-safety-study-of-pf-04171327-in-healthy-japanese-and-western-subjects-in-fasting-and-fed-conditions-103760https://curecurrent.com/trials/effects-of-administration-of-fostamatinib-on-blood-concentrations-of-digoxin-in-healthy-subjects-103761https://curecurrent.com/trials/effectiveness-of-water-exercises-on-isokinetic-muscle-strength-103762https://curecurrent.com/trials/a-proof-of-concept-and-dose-ranging-study-in-patients-with-rheumatoid-arthritis-103763https://curecurrent.com/trials/post-marketing-observational-study-in-subjects-with-rheumatoid-arthritis-103764https://curecurrent.com/trials/a-long-term-moderate-intervention-with-n-3-lc-pufa-supplemented-dairy-products-in-patients-with-rheumatoid-arthritis-103765https://curecurrent.com/trials/study-evaluating-the-clinical-remission-in-early-aggressive-rheumatoid-arthritis-103766https://curecurrent.com/trials/study-evaluating-the-safety-of-etanercept-in-rheumatoid-arthritis-ankylosing-spondylitis-and-psoriatic-arthritis-103767https://curecurrent.com/trials/evaluation-of-2-oral-doses-of-pg-760564-in-rheumatoid-arthritis-ra-patients-receiving-methotrexate-103768https://curecurrent.com/trials/efficacy-and-safety-of-adalimumab-in-patients-with-active-rheumatoid-arthritis-treated-concomitantly-with-methotrexate-103769https://curecurrent.com/trials/effect-of-cp-690-550-on-the-pharmacokinetics-of-metformin-in-healthy-volunteers-103770https://curecurrent.com/trials/study-evaluating-the-efficacy-and-safety-of-etanercept-and-methotrexate-in-japanese-subjects-with-rheumatoid-arthritis-103771https://curecurrent.com/trials/quality-of-life-outcomes-of-humira-in-rheumatoid-arthritis-ra-psoriatic-arthritis-psa-ankylosing-spondylitis-as-after-un-103772https://curecurrent.com/trials/cost-utility-analyses-of-adalimumab-treatment-in-patients-with-rheumatoid-arthritis-ra-103773https://curecurrent.com/trials/retrospective-evaluation-of-the-radiographic-efficacy-of-conventional-and-biologic-treatment-103774https://curecurrent.com/trials/safety-efficacy-and-pharmacokinetics-of-subcutaneous-acz885-in-patients-with-systemic-juvenile-idiopathic-arthritis-sjia-103775https://curecurrent.com/trials/restore-working-ability-in-rheumatoid-arthritis-103776https://curecurrent.com/trials/evaluation-of-eular-raid-score-in-rheumatoid-arthritis-patients-103777https://curecurrent.com/trials/multiple-dose-escalation-trial-of-pf-04308515-in-healthy-volunteers-103778https://curecurrent.com/trials/effects-of-administration-of-fostamatinib-on-blood-concentrations-of-rifampicin-in-healthy-subjects-103779https://curecurrent.com/trials/vagus-nerve-stimulation-in-rheumatoid-arthritis-103780https://curecurrent.com/trials/study-evaluating-impact-of-the-use-of-a-computer-based-tool-on-the-clinical-management-of-ra-patients-103781https://curecurrent.com/trials/evaluation-of-the-brada-and-abilhand-questionnaires-103782https://curecurrent.com/trials/effects-of-administration-of-fostamatinib-on-blood-concentrations-of-pioglitazone-in-healthy-subjects-103783https://curecurrent.com/trials/efficacy-and-safety-of-adalimumab-80-mg-every-other-week-with-methotrexate-103784https://curecurrent.com/trials/substudy-low-dose-of-abatacept-in-subjects-with-rheumatoid-arthritis-103785https://curecurrent.com/trials/self-injection-of-adalimumab-in-adult-japanese-subjects-with-rheumatoid-arthritis-103786https://curecurrent.com/trials/study-evaluating-efficacy-safety-of-etanercept-methotrexate-compared-to-usual-treatment-in-moderate-ra-subjects-103787https://curecurrent.com/trials/a-study-of-fostamatinib-in-subjects-with-impaired-kidney-function-103788https://curecurrent.com/trials/safety-tolerance-pharmacokinetics-and-activity-of-he3286-in-patients-with-rheumatoid-arthritis-103789https://curecurrent.com/trials/randomized-double-blind-placebo-controlled-study-to-assess-fatigue-in-patients-with-acd-due-to-ra-receiving-procrit-103790https://curecurrent.com/trials/applications-for-methotrexate-optimization-in-rheumatoid-arthritis-103791https://curecurrent.com/trials/six-month-clinical-research-study-for-patients-with-moderate-or-severe-dry-eye-syndrome-103792https://curecurrent.com/trials/cord-blood-serum-in-the-treatment-of-ocular-surface-diseases-103793https://curecurrent.com/trials/tbe-vaccine-to-patients-with-rheumatoid-arthritis-who-are-using-immunosuppressive-drugs-103794https://curecurrent.com/trials/study-of-the-safety-of-ce-224-545-and-methotrexate-in-patients-with-rheumatoid-arthritis-103795https://curecurrent.com/trials/apart-advanced-profiling-of-anti-rheumatic-therapies-103796https://curecurrent.com/trials/a-study-of-oral-scio-469-pharmacokinetics-study-of-a-drug-in-the-body-to-watch-how-the-drug-is-absorbed-distributed-meta-103797https://curecurrent.com/trials/a-study-of-the-safety-and-effectiveness-of-infliximab-remicade-in-patients-with-rheumatoid-arthritis-103798https://curecurrent.com/trials/open-label-pilot-protocol-of-patients-with-rheumatoid-arthritis-who-switch-to-infliximab-after-incomplete-response-to-et-103799https://curecurrent.com/trials/a-safety-and-efficacy-study-for-infliximab-remicade-with-methotrexate-in-patients-with-early-rheumatoid-arthritis-103800https://curecurrent.com/trials/the-infliximab-rheumatoid-arthritis-methotrexate-tapering-iramt-protocol-103801https://curecurrent.com/trials/study-evaluating-the-combination-of-etanercept-and-methotrexate-in-rheumatoid-arthritis-subjects-103802https://curecurrent.com/trials/changes-in-the-use-of-opioids-antidepressants-and-benzodiazepines-in-rheumatoid-arthritis-patients-treated-with-biologic-103803https://curecurrent.com/trials/a-study-of-the-safety-and-effectiveness-of-infliximab-remicade-in-patients-with-juvenile-rheumatoid-arthritis-103804https://curecurrent.com/trials/efficacy-of-oncoxin-plus-viusid-in-the-treatment-of-rheumatoid-arthritis-103805https://curecurrent.com/trials/rheumatoid-arthritis-dmard-intervention-and-utilizationstudy-103806https://curecurrent.com/trials/rheumatoid-arthritis-dmard-intervention-and-utilizationstudy-103807https://curecurrent.com/trials/glpg0259-in-methotrexate-refractory-rheumatoid-arthritis-103808https://curecurrent.com/trials/a-study-of-adalimumab-when-added-to-inadequate-standard-anti-rheumatic-therapy-in-patients-with-active-rheumatoid-arthri-103809https://curecurrent.com/trials/a-study-of-abatacept-in-japanese-patients-with-active-rheumatoid-arthritis-while-receiving-methotrexate-103810https://curecurrent.com/trials/vaccination-study-of-abatacept-bms-188667-for-normal-healthy-volunteers-103811https://curecurrent.com/trials/study-comparing-80-mg-of-adalimumab-with-placebo-and-demonstrating-the-non-inferiority-of-monthly-80-mg-adalimumab-dosin-103812https://curecurrent.com/trials/adalimumab-in-adult-japanese-subjects-with-rheumatoid-arthritis-103813https://curecurrent.com/trials/adalimumab-in-adult-japanese-subjects-with-rheumatoid-arthritis-103814https://curecurrent.com/trials/safety-and-efficacy-study-of-adalimumab-in-adult-chinese-rheumatoid-arthritis-subjects-treated-with-methotrexate-103815https://curecurrent.com/trials/a-study-to-compare-the-amount-of-cp-690-550-that-is-absorbed-into-the-blood-of-healthy-subjects-following-oral-administr-103816https://curecurrent.com/trials/evaluation-of-walk-with-ease-in-arthritis-103817https://curecurrent.com/trials/the-3dknee-system-a-post-market-study-103818https://curecurrent.com/trials/vaccination-against-pertussis-tetanus-and-diphtheria-in-patients-suffering-from-rheumatoid-arthritis-103819https://curecurrent.com/trials/methotrexate-polyglutamate-levels-as-a-marker-for-the-clinical-outcome-in-the-treatment-of-rheumatoid-arthritis-103820https://curecurrent.com/trials/retrospective-study-of-the-linear-hip-103821https://curecurrent.com/trials/efficacy-of-the-clp-hip-retrospective-103822https://curecurrent.com/trials/the-genetic-and-the-functional-study-of-dna-repair-system-and-the-susceptibility-to-rheumatoid-arthritis-103823https://curecurrent.com/trials/effects-of-hmg-coa-reductase-inhibitor-on-rheumatoid-arthritis-103824https://curecurrent.com/trials/ultrasonographic-monitoring-of-response-to-infliximab-in-patients-with-rheumatoid-arthritis-103825https://curecurrent.com/trials/a-rheumatoid-arthritis-ra-study-treating-signs-and-symptoms-of-ra-in-people-with-ra-receiving-methotrexate-103826https://curecurrent.com/trials/leflunomide-in-rheumatoid-arthritis-103827https://curecurrent.com/trials/safety-and-efficacy-study-of-tranilast-in-patients-with-active-rheumatoid-arthritis-ra-103828https://curecurrent.com/trials/bucillamine-study-of-holding-remission-after-infliximab-dose-off-103829https://curecurrent.com/trials/the-effect-of-adalimumab-humira-on-vascular-abnormalities-in-rheumatoid-arthritis-a-pilot-study-103830https://curecurrent.com/trials/study-of-human-leukocyte-antigen-hla-polymorphisms-in-patients-with-rheumatoid-arthritis-103831https://curecurrent.com/trials/the-study-of-abatacept-in-combination-with-etanercept-103832https://curecurrent.com/trials/a-study-to-assess-the-pharmacokinetics-of-methotrexate-given-with-and-without-azd9056-in-rheumatoid-arthritis-patients-103833https://curecurrent.com/trials/a-study-of-the-safety-and-pharmacokinetics-of-pro283698-in-patients-with-rheumatoid-arthritis-103834https://curecurrent.com/trials/cross-over-study-to-investigate-retinal-function-following-administration-of-a-single-dose-of-azd9056-103835https://curecurrent.com/trials/study-evaluating-epidemiology-of-rheumatoid-arthritis-psoriatic-arthritis-and-ankylosing-spondylitis-in-australia-103836https://curecurrent.com/trials/ultracet-tramadol-hydrochloride-and-acetaminophen-for-the-treatment-of-rheumatoid-arthritis-pain-103837https://curecurrent.com/trials/a-study-of-the-effect-on-pain-control-of-treatment-with-fentanyl-administered-through-the-skin-in-patients-with-rheumato-103838https://curecurrent.com/trials/pharmacokinetics-and-tolerability-of-subcutaneous-administration-of-pf-04236921-in-healthy-volunteers-103839https://curecurrent.com/trials/remission-and-joint-damage-progression-in-early-rheumatoid-arthritis-103840https://curecurrent.com/trials/efficacy-and-safety-of-tocilizumab-in-combination-with-dmards-in-patients-with-moderate-to-severe-rheumatoid-arthritis-103841https://curecurrent.com/trials/a-study-to-evaluate-the-efficacy-of-tacrolimus-in-rheumatoid-arthritis-patients-shown-unsuccessful-response-to-methotrex-103842https://curecurrent.com/trials/spring-scio-469-patients-with-rheumatoid-arthritis-not-receiving-methotrexate-103843https://curecurrent.com/trials/a-study-to-examine-the-effect-of-particle-size-on-bioequivalence-and-bioavailability-103844https://curecurrent.com/trials/a-study-to-compare-the-amount-of-tasocitinib-cp-690-550-that-is-absorbed-into-the-blood-of-healthy-subjects-following-or-103845https://curecurrent.com/trials/leflunomide-efficacy-response-related-to-dosing-regimen-in-early-rheumatoid-arthritis-103846https://curecurrent.com/trials/a-study-to-evaluate-the-effect-of-food-on-how-tasocitinib-cp-690-550-is-absorbed-and-moves-through-the-body-following-or-103847https://curecurrent.com/trials/effect-of-patient-cost-sharing-on-treatment-discontinuation-among-rheumatoid-arthritis-patients-103848https://curecurrent.com/trials/observational-study-of-rituxan-in-rheumatoid-arthritis-patients-in-routine-clinical-practice-103849https://curecurrent.com/trials/a-12-month-phase-3-open-label-multi-center-study-to-evaluate-the-long-term-safety-of-pn400-vimovo-103850https://curecurrent.com/trials/study-comparing-etanercept-with-usual-dmard-therapy-in-subjects-with-rheumatoid-arthritis-in-the-asia-pacific-region-103851https://curecurrent.com/trials/n-3-and-n-6-fatty-acids-in-rheumatoid-arthritis-103852https://curecurrent.com/trials/treatment-of-salivary-gland-hypofunction-with-neuro-electrostimulation-103853https://curecurrent.com/trials/local-analgesia-in-knee-and-hipatroplastic-surgery-in-patients-with-rheumatic-disease-extra-vs-intracapsulare-position-o-103854https://curecurrent.com/trials/a-study-to-estimate-the-amount-of-cp-690-550-study-drug-that-is-absorbed-into-the-blood-of-healthy-subjects-following-or-103855https://curecurrent.com/trials/enbrel-liquid-immunogenicity-protocol-103856https://curecurrent.com/trials/pain-inhibition-in-patients-with-rheumatoid-arthritis-and-central-sensitivity-syndromes-103857https://curecurrent.com/trials/safety-and-efficacy-of-anti-pandemic-h1n1-vaccination-in-rheumatic-diseases-103858https://curecurrent.com/trials/a-study-of-the-taste-of-different-oral-liquid-preparations-of-cp-690-550-in-trained-adult-product-testers-103859https://curecurrent.com/trials/efficacy-and-safety-of-tak-783-in-subjects-with-rheumatoid-arthritis-103860https://curecurrent.com/trials/a-drug-interaction-study-between-tocilizumab-methotrexate-and-simvastatin-on-patients-with-rheumatoid-arthritis-103861https://curecurrent.com/trials/a-study-to-assess-the-effect-of-tocilizumab-methotrexate-on-signs-and-symptoms-in-patients-with-moderate-to-severe-activ-103862https://curecurrent.com/trials/safety-and-efficacy-of-tak-715-in-subjects-with-rheumatoid-arthritis-103863https://curecurrent.com/trials/study-of-lx3305-and-methotrexate-in-subjects-with-stable-rheumatoid-arthritis-103864https://curecurrent.com/trials/comparative-efficacy-safety-study-of-esomeprazole-versus-placebo-for-the-prevention-of-gastric-and-duodenal-ulcers-with-103865https://curecurrent.com/trials/efferocytosis-and-genomic-polymorphism-in-autoimmune-diseases-103866https://curecurrent.com/trials/safety-study-of-scio-469-to-treat-patients-with-active-rheumatoid-arthritis-receiving-methotrexate-103867https://curecurrent.com/trials/study-of-mdx-1100-anti-cxcl10-human-monoclonal-antibody-in-combination-with-methotrexate-in-subjects-with-active-rheumat-103868https://curecurrent.com/trials/folatescan-in-autoimmune-disease-103869https://curecurrent.com/trials/early-migration-in-a-high-congruent-rotating-platform-total-knee-prosthesis-design-103870https://curecurrent.com/trials/assessment-of-inflammatory-biomarkers-expressed-in-a-sjogren-s-population-effect-of-a-topical-steroid-intervention-103871https://curecurrent.com/trials/complement-regulatory-proteins-expression-and-clinical-response-in-rheumatoid-arthritis-ra-patients-treated-with-rituxim-103872https://curecurrent.com/trials/assessment-of-rituximab-s-immunomodulatory-synovial-effects-the-arise-study-103873https://curecurrent.com/trials/3dknee-system-vs-the-mjs-knee-system-103874https://curecurrent.com/trials/a-multiple-dose-study-to-evaluate-subcutaneous-amg-108-in-subjects-with-rheumatoid-arthritis-103875https://curecurrent.com/trials/multiple-ascending-dose-study-of-bms-582949-in-patients-with-stable-rheumatoid-arthritis-on-the-methotrexate-background-103876https://curecurrent.com/trials/effectiveness-of-occupational-therapy-in-patients-with-rheumatoid-arthritis-rct-103877https://curecurrent.com/trials/association-of-fear-of-falling-and-physical-activity-in-rheumatoid-arthritis-comparison-before-and-after-biological-ther-103878https://curecurrent.com/trials/dose-ranging-study-of-art621-in-subjects-diagnosed-with-rheumatoid-arthritis-taking-methotrexate-103879https://curecurrent.com/trials/dose-optimisation-study-of-art621-in-subjects-diagnosed-with-rheumatoid-arthritis-taking-methotrexate-103880https://curecurrent.com/trials/long-term-treatment-study-of-mra-for-rheumatoid-arthritis-ra-from-study-mra213jp-103881https://curecurrent.com/trials/phase-open-label-study-of-mra-for-rheumatoid-arthritis-ra-103882https://curecurrent.com/trials/comparison-of-the-tuberculin-skin-test-tst-and-quantiferon-tb-gold-test-qft-g-in-patients-with-rheumatoid-arthritis-bein-103883https://curecurrent.com/trials/evaluation-of-the-efficacy-of-combination-treatment-with-anakinra-and-pegsunercept-in-improving-rheumatoid-arthritis-103884https://curecurrent.com/trials/juvenile-rheumatoid-arthritis-103885https://curecurrent.com/trials/evaluating-kineret-anakinra-in-rheumatoid-arthritis-ra-subjects-using-aself-reported-questionnaire-103886https://curecurrent.com/trials/the-spectra-study-103887https://curecurrent.com/trials/evaluation-of-quality-of-life-changes-in-puerto-rican-subjects-with-active-rheumatoid-arthritis-treated-with-humira-103888https://curecurrent.com/trials/effectiveness-and-safety-of-enbrel-etanercept-in-rheumatoid-arthritis-subjects-who-have-failed-remicade-infliximab-103889https://curecurrent.com/trials/vaccination-against-influenza-h1n1-in-rheumatic-diseases-103890https://curecurrent.com/trials/cell-immunity-response-to-vaccination-against-influenza-in-patients-with-rheumatoid-arthritis-103891https://curecurrent.com/trials/a-study-in-normal-healthy-people-testing-different-versions-of-a-pill-that-will-be-used-to-treat-rheumatoid-arthritis-103892https://curecurrent.com/trials/rheumatoid-arthritis-disease-activity-monitor-103893https://curecurrent.com/trials/study-evaluating-tmi-005-in-active-rheumatoid-arthritis-103894https://curecurrent.com/trials/targeting-synovitis-in-early-rheumatoid-arthritis-103895https://curecurrent.com/trials/a-study-to-evaluate-the-safety-of-escalating-doses-of-ocrelizumab-in-subjects-with-rheumatoid-arthritis-103896https://curecurrent.com/trials/sensitivity-of-echography-in-arthritis-103897https://curecurrent.com/trials/efficacy-and-safety-of-subcutaneous-versus-intravenous-acz885-in-adult-patients-with-established-rheumatoid-arthritis-103898https://curecurrent.com/trials/study-to-evaluate-the-efficacy-and-safety-of-orally-administered-rob-803-when-added-to-methotrexate-103899https://curecurrent.com/trials/allogeneic-mesenchymal-stem-cells-transplantation-for-primary-sj-gren-s-syndrome-pss-103900https://curecurrent.com/trials/comparison-of-adalimumab-and-infliximab-treatment-of-rheumatoid-arthritis-103901https://curecurrent.com/trials/study-of-intra-articular-delivery-of-tgaac94-in-inflammatory-arthritis-subjects-103902https://curecurrent.com/trials/pharmacogenetics-of-antifolate-disease-modifying-anti-rheumatic-drugs-in-rheumatoid-arthritis-in-taiwan-103903https://curecurrent.com/trials/pharmacogenetics-of-antifolate-drugs-in-autoimmune-diseases-in-taiwan-103904https://curecurrent.com/trials/a-study-to-investigate-the-potential-for-azd5672-to-affect-the-electrical-conduction-pathways-in-the-heart-103905https://curecurrent.com/trials/dose-escalating-multiple-dose-study-of-pd-0360324-in-combination-with-methotrexate-in-patients-with-rheumatoid-arthritis-103906https://curecurrent.com/trials/azd5672-bioavailability-study-in-healthy-male-and-female-subjects-103907https://curecurrent.com/trials/study-evaluating-etanercept-in-patients-with-rheumatoid-arthritis-ra-juvenile-idiopathic-arthritis-jia-or-psoriatic-arth-103908https://curecurrent.com/trials/study-of-controlled-release-formulations-of-ce-224-535-against-the-immediate-release-formulation-in-normal-volunteers-103909https://curecurrent.com/trials/study-evaluating-etanercept-in-patients-with-rheumatoid-arthritis-who-completed-trial-0881a1-301-eu-in-spain-103910https://curecurrent.com/trials/a-study-of-the-safety-tolerability-pharmacokinetics-and-pharmacodynamics-of-pf-04629991-in-healthy-volunteers-103911https://curecurrent.com/trials/treatment-of-arthritis-with-syk-kinase-inhibition-taski-1-103912https://curecurrent.com/trials/study-evaluating-the-clinical-and-therapeutic-management-of-rheumatoid-arthritis-in-spain-103913https://curecurrent.com/trials/mass-balance-and-metabolic-profiling-of-14c-azd5672-in-healthy-male-volunteers-103914https://curecurrent.com/trials/effects-of-hydroxychloroquine-on-oral-complaints-of-sj-gren-patients-103915https://curecurrent.com/trials/quality-of-sleep-in-patients-with-rheumatoid-arthritis-103916https://curecurrent.com/trials/assessment-of-safety-pharmacokinetics-and-efficacy-in-a-combination-treatment-with-smp-114-103917https://curecurrent.com/trials/evaluating-the-safety-of-extended-treatment-with-pegsunercept-peg-stnf-ri-in-subjects-with-rheumatoid-arthritis-ra-103918https://curecurrent.com/trials/study-examining-the-effect-of-exercise-in-people-with-rheumatoid-arthritis-taking-anti-tnfalpha-medication-103919https://curecurrent.com/trials/role-of-greyscale-and-power-doppler-sonography-in-therapy-monitoring-in-early-rheumatoid-arthritis-ra-103920https://curecurrent.com/trials/patients-with-rheumatoid-arthritis-ra-treated-with-rituximab-in-kuopio-university-hospital-103921https://curecurrent.com/trials/rituximab-treatment-in-sjogren-s-syndrome-103922https://curecurrent.com/trials/a-study-evaluating-the-safety-and-efficacy-of-cura-100-in-subjects-with-rheumatoid-arthritis-and-osteoarthritis-103923https://curecurrent.com/trials/etanercept-sfp-in-ra-patients-103924https://curecurrent.com/trials/a-pilot-study-of-potassium-supplementation-for-adult-patients-with-rheumatoid-arthritis-103925https://curecurrent.com/trials/phase-iii-comparative-study-open-label-of-mra-for-rheumatoid-arthritis-ra-103926https://curecurrent.com/trials/comparative-study-double-blind-of-mra-for-rheumatoid-arthritis-ra-103927https://curecurrent.com/trials/assessment-of-body-image-in-patients-with-rheumatoid-arthritis-103928https://curecurrent.com/trials/study-of-ngx267-oral-capsules-in-patients-with-xerostomia-associated-with-sjorgren-s-syndrome-103929https://curecurrent.com/trials/comparison-of-mtx-anti-tnf-to-mtx-conventional-dmards-in-patients-with-early-rheumatoid-arthritis-ra-who-failed-mtx-alon-103930https://curecurrent.com/trials/assessment-of-inflammatory-and-functional-changes-in-the-ocular-surface-associated-with-dry-eye-disease-103931https://curecurrent.com/trials/drug-drug-interaction-study-of-mra-in-patient-with-rheumatoid-arthritis-ra-103932https://curecurrent.com/trials/clinical-pharmacology-study-of-mra-in-patient-with-rheumatoid-arthritis-ra-with-renal-impairment-103933https://curecurrent.com/trials/rekindle-registry-with-enbrel-or-kineret-in-a-database-using-longitudinal-evaluations-103934https://curecurrent.com/trials/preference-of-rheumatoid-arthritis-ra-patients-of-enbrel-etanercept-auto-injector-versus-enbrel-pre-filled-syringes-103935https://curecurrent.com/trials/positron-emission-tomography-in-rheumatoid-arthritis-with-adalimumab-petra-103936https://curecurrent.com/trials/a-study-to-investigate-markers-of-inflammation-in-rheumatoid-arthritis-103937https://curecurrent.com/trials/gingival-wetness-and-gingival-crevicular-fluid-volume-in-patients-with-dry-mouth-103938https://curecurrent.com/trials/phase-ii-study-of-high-dose-cyclophosphamide-in-patients-with-severe-autoimmune-hematologic-disease-103939https://curecurrent.com/trials/health-related-quality-of-life-and-disease-related-costs-comparison-between-ankylosing-spondylitis-rheumatoid-arthritis-103940https://curecurrent.com/trials/objective-study-in-rheumatoid-arthritis-103941https://curecurrent.com/trials/infliximab-to-treat-children-with-juvenile-rheumatoid-arthritis-103942https://curecurrent.com/trials/treatment-of-rheumatoid-arthritis-with-marine-and-botanical-oils-103943https://curecurrent.com/trials/effects-of-pulsed-magnetic-pads-on-rheumatoid-arthritis-symptoms-in-postmenopausal-women-103944https://curecurrent.com/trials/a-phase-2-study-to-evaluate-the-safety-tolerability-and-activity-of-fontolizumab-in-subjects-with-active-rheumatoid-arth-103945https://curecurrent.com/trials/a-study-to-assess-the-safety-and-efficacy-of-adalimumab-when-added-to-inadequate-standard-anti-rheumatic-therapy-in-pati-103946https://curecurrent.com/trials/a-study-using-intravenous-paxceed-to-treat-patients-with-rheumatoid-arthritis-103947https://curecurrent.com/trials/a-prevalence-study-of-chronic-widespread-pain-cwp-among-patients-with-rheumatoid-arthritis-ra-and-control-population-in-103948https://curecurrent.com/trials/ramipril-in-rheumatoid-arthritis-103949https://curecurrent.com/trials/efficacy-and-safety-of-valdecoxib-and-naproxen-in-treating-the-signs-and-symptoms-of-rheumatoid-arthritis-ra-in-a-severe-103950https://curecurrent.com/trials/phase-i-study-evaluating-the-pharmacokinetic-profile-of-rhudex-103951https://curecurrent.com/trials/efficacy-study-of-mm-093-in-rheumatoid-arthritis-patients-on-methotrexate-mtx-103952https://curecurrent.com/trials/humira-in-rheumatoid-arthritis-do-bone-erosions-heal-103953https://curecurrent.com/trials/a-study-to-evaluate-the-efficacy-and-safety-of-celecoxib-suspension-compared-to-naproxen-suspension-in-patients-with-jra-103954https://curecurrent.com/trials/long-circulating-liposomal-prednisolone-versus-pulse-intramuscular-methylprednisolone-in-patients-with-active-rheumatoid-103955https://curecurrent.com/trials/the-use-of-anti-cd4-monoclonal-antibody-mab-fragment-for-the-imaging-of-chronic-inflammation-in-patients-with-active-rhe-103956https://curecurrent.com/trials/evaluation-of-the-efficacy-and-safety-of-intra-articular-etanercept-in-patients-with-refractory-knee-joint-synovitis-103957https://curecurrent.com/trials/lingzhi-and-sen-miao-san-for-the-treatment-of-rheumatoid-arthritis-103958https://curecurrent.com/trials/an-analysis-of-peripheral-blood-t-cell-subsets-on-rheumatoid-arthritis-103959https://curecurrent.com/trials/acupuncture-for-the-treatment-of-rheumatoid-arthritis-103960https://curecurrent.com/trials/study-to-evaluate-the-incidence-of-gastric-ulcers-following-administration-of-either-pn-200-or-naproxen-in-subjects-who-103961https://curecurrent.com/trials/early-access-program-of-the-safety-of-human-anti-tnf-monoclonal-antibody-adalimumab-in-subjects-with-active-rheumatoid-a-103962https://curecurrent.com/trials/assessment-of-the-effect-of-adalimumab-on-response-to-influenza-virus-and-pneumococcal-vaccines-in-subjects-with-rheumat-103963https://curecurrent.com/trials/study-of-adalimumab-administered-as-subcutaneous-injections-in-adult-chinese-rheumatoid-arthritis-subjects-treated-with-103964https://curecurrent.com/trials/open-label-study-to-assess-efficacy-and-safety-of-the-fully-human-anti-tnf-alpha-monoclonal-antibody-adalimumab-103965https://curecurrent.com/trials/study-of-the-human-anti-tnf-monoclonal-antibody-in-patients-with-active-rheumatoid-arthritis-103966https://curecurrent.com/trials/a-study-of-adalimumab-in-adult-japanese-subjects-with-rheumatoid-arthritis-103967https://curecurrent.com/trials/a-phase-2-study-to-evaluate-the-efficacy-and-safety-of-60mg-of-mm-093-in-patients-with-active-rheumatoid-arthritis-103968https://curecurrent.com/trials/ancillary-study-to-protocol-20060104-103969https://curecurrent.com/trials/assessment-of-the-effectiveness-of-low-level-laser-therapy-on-the-hands-of-patients-with-rheumatoid-arthritis-103970https://curecurrent.com/trials/meditation-based-stress-reduction-in-rheumatoid-arthritis-103971https://curecurrent.com/trials/genetic-and-immune-studies-of-rheumatoid-arthritis-and-related-conditions-103972https://curecurrent.com/trials/positron-emission-tomography-and-magnetic-resonance-imaging-to-evaluate-synovial-blood-flow-in-rheumatoid-arthritis-pati-103973https://curecurrent.com/trials/the-safety-and-efficacy-of-chicken-type-ii-collagen-on-uveitis-associated-with-juvenile-rheumatoid-arthritis-103974https://curecurrent.com/trials/dhea-treatment-for-sjogren-s-syndrome-103975https://curecurrent.com/trials/tnrf-fc-to-treat-eye-inflammation-in-juvenile-rheumatoid-arthritis-103976https://curecurrent.com/trials/steroid-hormones-th1-th2-cytokines-and-reproductive-status-103977https://curecurrent.com/trials/potential-of-transplanted-stem-cells-to-mature-into-salivary-gland-and-cheek-cells-103978https://curecurrent.com/trials/the-role-of-cytokines-on-growth-hormone-suppression-in-premenopausal-women-with-rheumatoid-arthritis-and-the-effect-of-t-103979https://curecurrent.com/trials/study-of-oral-bacteria-in-patients-with-dry-mouth-103980https://curecurrent.com/trials/the-functioning-of-immune-and-hormonal-systems-in-patients-with-sjogren-s-syndrome-and-in-healthy-volunteers-103981https://curecurrent.com/trials/prognostic-indicators-and-determinants-of-the-2-5-year-outcome-in-a-cohort-of-early-synovitis-patients-103982https://curecurrent.com/trials/the-pathogenesis-of-inflammatory-synovitis-a-study-of-early-arthritis-103983https://curecurrent.com/trials/infliximab-for-the-treatment-of-early-rheumatoid-arthritis-103984https://curecurrent.com/trials/treating-rheumatoid-arthritis-with-tripterygium-wilfordi-hook-f-or-sulfasalazine-103985https://curecurrent.com/trials/pilot-study-of-thalidomide-to-treat-sjogren-s-syndrome-103986https://curecurrent.com/trials/treatment-of-dry-eye-syndrome-with-cyclosporin-a-eye-drops-103987https://curecurrent.com/trials/methotrexate-alone-versus-combination-of-methotrexate-and-subcutaneous-fludarabine-for-severe-rheumatoid-arthritis-safet-103988https://curecurrent.com/trials/etanercept-therapy-for-sjogren-s-syndrome-103989https://curecurrent.com/trials/safety-tolerability-pharmacokinetics-and-pharmacodynamics-of-acz885-in-patients-with-rheumatoid-arthritis-with-ongoing-t-103990https://curecurrent.com/trials/phase-1-dose-escalation-study-of-intra-articular-administration-of-tgaac94-103991https://curecurrent.com/trials/study-of-a-large-protein-molecule-administered-with-escalating-doses-of-recombinant-human-hyaluronidase-103992https://curecurrent.com/trials/study-of-the-scandinavian-total-ankle-replacement-star-for-the-treatment-of-bilateral-degenerative-ankle-disease-103993https://curecurrent.com/trials/dose-escalating-study-of-bg9924-in-combination-with-methotrexate-in-active-rheumatoid-arthritis-103994https://curecurrent.com/trials/study-evaluating-the-efficacy-of-enbrel-etanercept-in-subjects-in-japan-103995https://curecurrent.com/trials/phase-2-amg-714-in-rheumatoid-arthritis-103996https://curecurrent.com/trials/anakinra-kineret-in-combination-with-disease-modifying-anti-rheumatic-drugs-dmards-in-subjects-with-active-rheumatoid-ar-103997https://curecurrent.com/trials/study-evaluating-enbrel-in-patients-with-rheumatoid-arthritis-103998https://curecurrent.com/trials/study-evaluating-the-tolerance-and-safety-of-enbrel-etanercept-in-adults-and-children-103999https://curecurrent.com/trials/study-to-evaluate-the-pharmacokinetic-interaction-between-pla-695-and-methotrexate-in-adults-with-rheumatoid-arthritis-104000https://curecurrent.com/trials/study-evaluating-the-efficacy-and-safety-of-etanercept-in-chinese-subjects-with-rheumatoid-arthritis-104001https://curecurrent.com/trials/study-evaluating-health-related-utility-in-rheumatoid-arthritis-104002https://curecurrent.com/trials/phase-2-clinical-study-in-rheumatoid-arthritis-with-an-investigational-oral-p38-map-kinase-inhibitor-vx-702-104003https://curecurrent.com/trials/a-study-in-rheumatoid-arthritis-with-an-investigational-oral-p38-map-kinase-inhibitor-vx-702-104004https://curecurrent.com/trials/a-study-evaluating-10-mg-and-25-mg-doses-of-etanercept-in-patients-with-rheumatoid-arthritis-104005